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ABSTRACT 
The trans-differentiation of injury-activated fibroblasts to myofibroblasts is a 
process that provides contractile strength for wound closure. Persistent myofibroblast 
differentiation, however, is associated with fibrotic pathologies such as organ fibrosis, 
vascular remodeling, and atherosclerotic plaque formation. Myofibroblasts acquire a 
contractile phenotype with biochemical properties characteristic of both smooth muscle 
cells and stromal fibroblasts. The cyto-contractile protein, smooth muscle "-actin 
(SM"A) is a biomarker of myofibroblast differentiation. Expression of the SM"A gene, 
ACTA2, is regulated by cis-acting elements and transcription factors that activate or 
repress the ACTA2 promoter.   
 
Purine-rich element binding proteins A (Pur") and B (Pur!) are sequence-
specific, single-stranded DNA (ssDNA)/RNA-binding proteins that act as transcriptional 
repressors of ACTA2 expression. Both Pur proteins interact with the purine-rich strand of 
a cryptic muscle-CAT (MCAT) enhancer motif in 5’-flanking region of the ACTA2 
promoter. Despite significant sequence homology with Pur", Pur! was identified as the 
dominant repressor of ACTA2 expression in mouse embryonic fibroblasts and vascular 
smooth muscle cells by virtue of gain-of function and loss-of-function analyses in 
cultured cells. Biophysical studies indicated that Pur! reversibly self-associates in 
solution to form a homodimer. Quantitative DNA-binding assays revealed that Pur! 
interacts with the purine-rich strand of the ACTA2 MCAT motif via a cooperative, 
multisite binding mechanism to form a high-affinity 2:1 Pur!-ssDNA complex.   
 
In this dissertation, a combination of computational, biochemical, and cell-based 
approaches were employed to elucidate the molecular basis of Pur! repressor interaction 
with the ACTA2 gene. Limited proteolysis of recombinant mouse Pur! in the presence 
and absence of the purine-rich strand of the ACTA2 MCAT element led to the 
identification of a core ssDNA-binding region that retains the ability to dimerize in 
solution. Knockdown of endogenous Pur! in mouse embryonic fibroblasts via RNA 
interference induced SM"A expression and conversion to a myofibroblast-like 
phenotype. To map the specific structural domains in the core region of Pur! that account 
for its unique ACTA2 repressor and ssDNA-binding functions, computational homology 
models of the Pur! monomer and dimer were generated based on the x-ray crystal 
structure of an intramolecular subdomain of Drosophila melanogaster Pur". Empirical 
biochemical and cell-based analyses of rationally-designed Pur! truncation proteins 
revealed that the assembled Pur! homodimer is composed of three separate purine-rich 
ssDNA-binding subdomains. Evaluation of the effects of anionic detergent and high-salt 
on the binding of Pur! to ssDNA implicated the involvement of hydrophobic and 
electrostatic interactions in mediating high-affinity nucleoprotein complex formation. 
This inference was validated by site-directed mutagenesis experiments, which identified 
several basic amino acid residues required for the ACTA2 repressor activity of Pur!. 
Collectively, the findings described herein establish the structural and chemical basis for 
the cooperative interaction of Pur! with the ACTA2 MCAT enhancer and for Pur!-
dependent suppression of myofibroblast differentiation. 
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
Tissue remodeling is a normal physiological process that occurs during wound 
healing following injury. Chronic remodeling, however, plays a significant role in the 
progression of pathological fibrotic diseases such as hypertrophic scarring, organ fibrosis, 
and dysfunctional vascular remodeling contributing to atherosclerosis and restenosis. A 
long-standing goal in the field has been to understand the molecular processes that 
contribute to pathological tissue remodeling and fibrotic disease. The myofibroblast is a 
specialized cell type that emerges during wound healing and plays a fundamental role in 
tissue remodeling by synthesizing extra cellular matrix (ECM) components and providing 
contractile force for wound closure. It is well accepted that the formation of these unique 
cells relies on trans-differentiation of non-contractile resident fibroblasts to form smooth 
muscle cell (SMC)-like myofibroblasts with a contractile phenotype. An understanding of 
the molecular mechanisms that regulate trans-differentiation of fibroblasts in vascular 
remodeling, wound healing, and tissue repair may elucidate therapeutic strategies for 
treating diseases associated with persistent tissue remodeling. The phenotype of SMCs 
and growth-activated fibroblasts correlates with the relative expression level of 
contractile protein smooth muscle "-actin (SM"A). The gene encoding SM"A, ACTA2, 
is regulated by a network of transcriptional activators and repressors. Purine-rich element 
binding proteins A (Pur") and B (Pur!) are transcriptional repressors of the SM"A gene, 
ACTA2, and have been implicated in regulation of stromal cell phenotype. The following 
literature review will summarize experimental studies that have shaped our current 
understanding of Pur proteins, their involvement in molecular pathways that regulate 
 2 
smooth muscle "-actin expression, and ultimately trans-differentiation of fibroblasts to 
myofibroblasts. Elucidation of the molecular mechanisms that control myofibroblast 
differentiation may have significant implications in human health and in the development 
of therapeutic strategies for treating fibrotic disease. 
 
1.1 TISSUE REPAIR AND FIBROSIS 
Wound healing is a complex process that restores tissue continuity subsequent to 
injury. Remodeling of connective tissue during normal wound healing involves a two-
step process whereby fibroblasts acquire a contractile and reparative phenotype. Tissue 
injury disrupts the composition and organization of the ECM in healthy tissues and 
causes resident cells to experience a loss in stress shielding from environmental 
mechanical tension (1, 2). The initial stage of wound healing, epithelialization, relies on 
an increase in growth factors surrounding the site of injury and triggers local fibroblast 
cells to migrate into the site of damaged tissue. Prior to injury, cells have very few actin-
associated contacts with the ECM or other cells but activated fibroblasts acquire a 
migratory phenotype during epithelialization and are characterized by de novo acquisition 
of contractile bundles, stress fibers, and focal adhesions consisting of cytoplasmic actins 
(3, 4). These activated fibroblasts have been termed proto-myofibroblasts (4). The second 
step of wound healing involves the formation and contraction of granulation tissue. 
Increased mechanical stress as a result of continued remodeling on the ECM triggers 
proto-myofibroblasts to differentiate into myofibroblasts. This transition is marked by an 
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increase in SM"A expression which enhances the contractility of myofibroblasts and 
leads to the formation and contraction of granulation tissue (5). The final stage of wound 
healing results in restoration of tissue continuity, minimization of wound size, and scar 
formation. The scar is composed of connective tissue, ECM constituents, and blood 
vessels deposited during tissue repair (6). After epithelialization occurs, myofibroblasts 
undergo apoptosis resulting in diminished SM"A expression, lower myofibroblast 
population, and a reduction of granulation tissue within the scar (7).  
Although transient myofibroblast differentiation plays a critical role in restoration 
of healthy connective tissue during wound healing, persistent myofibroblast activation 
can lead to chronic pathological fibrosis. Continual myofibroblast contraction and 
excessive secretion of ECM is referred to as “endless healing” (6). Endless healing leads 
to serious pathologies associated with numerous fibrocontractive diseases that often result 
in severe complications such as organ dysfunction or hypertrophic scarring. Hypertrophic 
scarring is a consequence of deficiency in apoptotic removal of myofibroblasts and an 
excessive build-up of collagen matrix. Tissue deformation in hypertrophic scarring is 
common in healing burn wounds, fibrotic scleroderma, and Dupuytren’s disease (8). 
Organ dysfunction of the heart (9, 10), kidney (11), or liver (12) can result from chronic 
differentiation of myofibroblasts and excessive production of ECM proteins (9, 12, 13). 
Severe airway myofibroblast remodeling in the lung, has been observed in idiopathic 
pulmonary fibrosis, bronchopulmonary dysplasia, alveolar fibrosis, and interstitial 
pneumonitis (14-17). Additionally, dysfunctional myofibroblast remodeling creates a 
favorable microenvironment for epithelial tumor cells in a stromal reaction that enhances 
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cancer progression (14, 15, 18, 19). Myofibroblasts have also been identified in vein graft 
remodeling, coronary transplant, and systemic and pulmonary hypertension.  
Vascular fibroblasts that acquire a myofibroblast-like phenotype play a significant 
role in atherosclerotic plaque formation and persistent vascular remodeling (20). Fibrosis 
within the arterial intima results in persistent secretion of cytokines and proteolytic 
enzymes induced by inflammation. This negative remodeling is associated with high-
grade stenosis in cardiovascular disease. Increased synthesis of SM"A, collagen matrix, 
and stress fibers is likely to contribute to the pathological constrictive remodeling 
associated with nonstented arteries. A porcine model revealed extensive proliferation of 
adventitial fibroblasts and ECM production in response to a dissecting medial injury (21-
23). The origin of adventitial fibroblasts in vascular remodeling is widely debated. 
Proliferating adventitial fibroblasts labeled with bromodeoxyuridine traced migration of 
these cells from the adventitia to the media suggesting that these myofibroblast-like 
adventitial cells have the ability to translocate from the site of origin and contribute to 
vascular remodeling (21, 23). Although these results cannot exclude the possibility of 
mislabeled medial SMCs, another study observed the migration of labeled perivascular 
fibroblasts into the arterial intima following the introduction of a saphenous vein graft 
(24). These results suggest that vascular fibroblasts have the capacity to differentiate into 
myofibroblasts and participate in cellular remodeling of vessels.  
In addition to fibroblasts, several reports indicate that there may be alternative 
cellular precursors that modulate into myofibroblasts (25). Myofibroblast progenitor cells 
including Hepatic Stellate Cells (HSCs) in liver fibrosis (12, 26, 27) and bone marrow 
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(BM)-derived fibrocytes in kidney (9, 12, 25, 28), liver (12), and pulmonary fibrosis (17, 
28, 29) are thought to be alternative sources for myofibroblast differentiation. 
Additionally, cancer invasion depends on a stromal reaction that requires myofibroblast 
formation from endothelial and epithelial cells (19). Importantly, myofibroblasts in blood 
vessels may be derived from vascular SMCs. Of particular interest is the dedifferentiation 
of medial SMCs to form myofibroblasts during the development of atherosclerotic 
plaques and restenoic lesions (30). Medial SMCs, adventitial fibroblasts, and bone-
marrow derived cells have all been implicated in the progression of atherosclerotic plaque 
fibrosis (20, 31, 32). Chronic inflammation of the arterial intima results in accumulation 
of inflammatory cells and ECM which triggers translocation of SMCs to the 
atherosclerotic plaque (33). Recent studies have suggested that SMCs may dedifferentiate 
to form myofibroblasts in response to the progression of coronary atherosclerotic and 
restenoic lesion formation (30). During the progression of vascular disease, studies have 
noted a decrease in markers of differentiated SMCs such as smoothelin and smooth 
muscle myosin heavy chain in the media and intima of human coronary arteries while 
retaining the common SM"A biomarker (34, 35). To date, myofibroblasts have been 
detected in most fibrotic pathologies suggesting that they play a key role in disease 
progression. 
1.2 MYOFIBROBLASTS 
Myofibroblasts were first identified in the granulation tissue of dermal wounds by 
Gabbiani et al in 1971 (36). Electron microscopy images of granulation tissue detected a 
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cell type with characteristics of both a SMC and fibroblast. Chemical and immunologic 
experiments showed that fibroblasts at the site of wound healing have morphological 
features of a contractile cell and generate a contractile apparatus composed of thick fibril 
bundles. Due to the fibroblastic and SMC characteristics, this intermediate modified cell-
type was termed myofibroblast. Since their identification, myofibroblasts have been 
identified in nearly all physiological conditions involving fibrosis and tissue remodeling 
(12). They are essential for generating contractile force during wound healing and 
pathological fibrosis. 
Myofibroblasts are a unique cell type that form when fibroblasts or other 
progenitor cells differentiate and acquire SMC-like features in response to tissue injury. 
The myofibroblast is a phenotypically modulated cell type that exhibits properties of both 
fibroblasts and SMCs (36). The contractile apparatus is a key morphological feature of 
myofibroblasts and contains contractile proteins including non-muscle myosin and actin 
microfilament bundles (37-39). The intracellular actin bundles are linked to extracellular 
fibronectin fibrils through a fibronexus adhesion complex (37, 40, 41). The formation of 
this mechano-transduction system allows for transmission of extracellular mechanical 
effectors to influence intracellular signals. The force produced by intracellular stress 
fibers is also transmitted to the ECM through this transduction system (37, 42, 43). 
Notably, the contractile proteins expressed during the fibroblast to myofibroblast trans-
differentiation reflect the phenotype of the cell. Phenotypic modulation of fibroblasts into 
proto-myofibroblasts is characterized by the appearance of stress fibers consisting of 
cytoplasmic !- and $-actin (4). These actin forms are absent in differentiated 
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myofibroblasts and replaced by the SM"A containing stress fibers (44). Unlike SMCs, 
myofibroblasts do not have a notable expression of smooth muscle myosin heavy chain, 
desmin, h-caldesmon, and smoothelin. Although the identification of a single marker of 
SMC and myofibroblast differentiation is impractical due to the diverse number of 
pathways involved in differentiation, there is a direct correlation between SM"A 
expression and the phenotype of myofibroblasts and SMCs (35). 
Expression of SM"A in myofibroblasts is regulated by a combination of factors. 
Although numerous serum growth factors including epidermal growth factor (EGF), 
insulin, and platelet-derived growth factor (PDGF)-BB are associated with injury-
activation of SM"A expression, transforming growth factor !1 (TGF!1) is considered 
the most critical activator of SM"A expression during proto-myofibroblast to 
myofibroblast differentiation. Inflammatory cells at the site of injury release cytokines 
which trigger resident cells to synthesize ED-A fibronectin (45) and ECM leading to 
localized expression of active TGF!1 (4, 46). Cells at the site of injury secrete latent 
TGF!1 (L-TGF!1) associated with a latency peptide (LAP) and form a complex with the 
latent TGF!1 binding protein-1 (LTBP-1). TGF!1 becomes activated by proteases 
released from resident epithelial cells, vascular endothelial cells, and immune cells that 
have taken residence in the ECM. During this step, TGF!1 undergoes conformational 
changes to take on an active form. Active TGF!1 binds to the transmembrane TGF!1 
receptors and upregulates fibronectin and collagen expression (47). This critical step 




1.3 SMOOTH MUSCLE "-ACTIN 
The mammalian actin family encompasses six isoforms of muscle and non-
muscle actin. Actin is a highly conserved eukaryotic protein that is 95% homologous with 
sites of sequence variation localized to the last 10-20 amino acids of the N-terminal tail 
(48). The SM"A isoform is a tissue-specific, muscle isoform that is ubiquitously 
expressed in stromal cell types and plays an important role in the cytoskeletal network, 
cell shape, cell differentiation, and mechanotransduction of biochemical signals (49-53).  
SM"A was originally identified in smooth muscle cells and occupies nearly 
40% of the total protein in vascular SMCs (54, 55). Sequence comparison of multiple 
actin isoforms revealed a unique N-terminal sequence, Ac-EEED, of SM"A (48), which 
led to the development of a monoclonal antibody that specifically recognizes the unique 
N-terminal epitope of SM"A (56). This antibody provided a method for measuring 
SM"A expression in granulation tissue. Since the development of this antibody, SM"A 
has been identified as a key component of the cytoskeleton required for transmission of 
contractile strength during SMC and myofibroblast differentiation in wound healing, 
pathological organ fibrosis, and persistent vascular remodeling (57-60). Consequently, 
SM"A is a prominent biomarker for myofibroblast differentiation. 
Generation of a SM"A gene knockout mouse suggested that SM"A-null mice 
have a normal survival rate and exhibit normal feeding and reproductive behaviors (61). 
However, SM"A is essential for vessel dilation (61), establishing a migratory phenotype 
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in myofibroblasts, and facilitating wound closure (4). Furthermore, the monoclonal 
antibodies that recognize the N-terminal epitope of SM"A prevented polymerization of 
SM"A (48, 62) and incubation of this peptide with fibroblast cells resulted in a decrease 
in contractile tension exhibited by myofibroblasts in vitro (58).  
The dynamic and tissue specific expression of SM"A results in phenotypic 
modulation of myocytes (62), vascular SMCs, and myofibroblasts (63). A distinct 
correlation between cellular phenotype of myofibroblasts and the level of SM"A 
expression has prompted scientists to evaluate the regulatory mechanisms that control the 
transcriptional regulation of SM"A gene expression.  
!
1.4 TRANSCRIPTIONAL REGULATION OF THE SM"A GENE 
Expression of the mammalian SM"A gene, ACTA2, is regulated by a complex 
network of cis-elements and trans-acting factors that facilitate promoter activation and 
repression. This intricate system involving numerous transcriptional regulatory proteins 
and their cognate binding sites provide the molecular framework for efficient phenotypic 
modulation of SM"A expression in stromal cell types (64). As stated previously, 
activation of SM"A gene transcription is triggered by a key agonist TGF!1 that has been 
activated by cytokines secreted by injured epithelial, endothelial, and immune cells that 
have migrated to the site of inflammation. Biomechanical stress induced by wound 
healing, ischemia, reperfusion and thrombosis, leads to de-repression of the ACTA2 
promoter thereby triggering the TGF!1 auto-regulatory signaling pathway, SM"A 
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expression, and myofibroblast differentiation (65). This section will review literature 
pertaining to the regulatory proteins and the cognate binding sites involved in ACTA2 
promoter activation and repression in myofibroblast cells with a focus on studies 
pertaining to the purine-rich element binding protein (Pur) family of transcriptional 
repressors.  
Interaction of active TGF!1 with the receptor II kinase complex induces 
phosphorylation of Smad2 and Smad3 transcription factors which associate with Smad4 
and migrate from the cytosol into the nucleus where they interact with regulatory DNA 
sequences and transcription factors to enhance ACTA2 expression (66, 67). The TGF!1-
dependent activation pathway also de-represses a 200 base pair (bp) region of the ACTA2 
5’-flanking region by eliminating repressor-DNA interactions (68-70) and excluding 
transcriptional repressor proteins from the nucleus. Sequence alignment studies have led 
to the identification of cis-regulatory elements that are highly conserved in promoter 
sequences of the human (71) and mouse (72) ACTA2 gene and contribute to activation of 
ACTA2. The ACTA2 promoter contains numerous cis-regulatory elements that have been 
identified within the 5’-flanking region of the ACTA2 gene. Most studies evaluating the 
impact of these regulatory sequences on ACTA2 activation were performed in aortic 
smooth muscle cells, AKR-2B mouse embryo fibroblast cells (MEFs), or BC3H1 
myogenic cells. Cis-regulatory elements that were identified include the promoter 
element (PE), bp -195 to -164, a TGF!-1 control element (TCE), bp -53 to -43, a TGF!-1 
hypersensitivity region (THR), bp -176 to -145, CArG elements, bp -120 to -111 and -70 
to -61, and an Sp1/3 binding sequence (SPUR), bp -59 to -28, and muscle-CAT (MCAT) 
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enhancer elements, bp -319 to -313, -182 to -176, and +3491 to +3496. For a 
diagrammatic view of the ACTA2 promoter, cis-elements, and associated transcription 
factors see Figure 1-1. In particular, the SPUR, CArG, and MCAT elements are key 
sequences for ACTA2 activation.  
The SPUR element is located within the guanine and cytosine-rich TCE and THR 
elements of the ACTA2 promoter and contributes to ACTA2 activation (73). Sp Kruppel-
like proteins are transcriptional activators of ACTA2 that interact with GC-rich 
(GGGGCGGGG) or GT-rich (GGTGTGGGG) sequences through a zinc-finger domain 
(74, 75). While both proteins activate ACTA2 expression, studies have identified 
additional roles for Sp1 in regulation of TGF!1-associated transcription and repression of 
smooth muscle myosin heavy chain (SM-MHC) and SM22" in fibroblasts (73, 76-78). 
Therefore, the interaction of Sp1/3 with SPUR sequences encoded in the THR and TCE 
elements of ACTA2 contribute to dedifferentiation of vascular SMCs and trans-
differentiation of fibroblasts to myofibroblasts. 
Multiple CArG elements, CC(A/T)6GG, are located within the 5’-flanking region 
of the ACTA2 promoter but their involvement in activation of SM"A expression during 
myofibroblast differentiation is currently under debate. Although several studies have 
predicted minimal involvement (79), a recent study showed that a CArG element in the 
first intron of the promoter activated SM"A expression in myofibroblasts (80). CArG 
element sequences were formerly identified in the 5’-flanking region of the "-cardiac 
actin promoter (81, 82). Similar sequences were also identified within other muscle-
specific genes and the serum response element (SRE) of early response genes including 
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c-fos, skeletal "-actin, and SM"A after serum stimulation (83-86). Serum response factor 
(SRF) activates the ACTA2 gene by interacting with CArG boxes, also referred to as the 
serum response element (SRE). Activation of genes encoding CArG boxes requires 
association of SRF with the coactivator, myocardin, the master regulator of SM"A gene 
expression (45, 87). Serum stimulation triggers activation of SM"A gene expression by 
prompting the translocation of cytoplasmic SRF into the nucleus where it forms a 
nucleoprotein complex with myocardin and CArG elements and triggers SM"A gene 
activation.  
MCAT enhancer elements and their cognate transcriptional activator, TEF-1, play 
a significant role in genetic regulation of muscle-specific genes. MCAT elements were 
first identified in the chicken cardiac troponin T promoter and are muscle-specific (88). 
Recent studies have shown that MCAT sequence elements are frequently located within 
the promoter region of cardiac, skeletal, and smooth muscle genes (89). The consensus 
sequence of the MCAT sequence element, 5’-CATTCCT-3’, was identified by selection 
binding site assays (90). MCAT elements are specific binding sites for members of the 
transcriptional enhancer factor family of activators (91, 92). The four members of the 
TEF family, including TEF-1 (92), RTEF-1 (93-97), ETF (94, 98), and DTEF-1 (96, 99, 
100), exhibit a conserved TEA DNA binding domain. TEF proteins preferentially bind 
the double-stranded MCAT element and lack the capacity to bind to the ssDNA 
conformation (101). The MCAT enhancer element is crucial for ACTA2 activation and 
RTEF-1 and DTEF-1 are thought to be the dominant inducible activators of ACTA2 in 
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!
Figure 1- 1. Transcriptional regulation of ACTA2 by a complex network of transcriptional 
regulatory factors. Activation of the ACTA2 promoter is facilitated by assembly of 
activator proteins on cis-regulatory elements proximal to the transcriptional start site. 
ACTA2 expression is activated upon binding of Sp1/3 proteins to the THR and SPUR 
(TCE) elements, association of multimeric SRF:myocardin complexes to CArG elements 
and association of TEF-1 with the cryptic MCAT enhancer motif. ACTA2 repression is 
facilitated by interaction of sequence-specific, ssDNA-binding proteins Pur", Pur!, and 
MSY1 with repressor binding sites proximal to the MCAT enhancer motif. Pur protein 
dimers may associate as homodimers or heterodimers of Pur" and Pur!. Pur proteins also 







myofibroblasts (102). Furthermore, the MCAT enhancer element is crucial for ACTA2 
activation (101, 103). 
The discovery of a cryptic MCAT enhancer element in ACTA2 led to the 
identification of a repressor sequence immediately 3’ of the MCAT element. Initially, cell 
based reporter gene assays were used to assess a 1.1 kb sequence located at the 5’-
flanking region of the transcription start site from the 13 kb ACTA2 gene (72). Sequence 
comparisons and cell based assays with reporter constructs of the ACTA2 5’-flanking 
region led to the detection of a 373-bp sequence that contained a promoter region 
(between bp -150 and -191) in the 5’-flanking region of ACTA2 proximal to the 
transcriptional start site. Original studies found that bp -191 and -150 contained sequence 
elements that were required for transcriptional activation of ACTA2 (104, 105). These 
studies also identified a 33-bp sequence (corresponding to bp -224 to -191) that plays a 
role in repressing ACTA2 transcription. Deletion or replacement of this element with a 
different sequence resulted in the enhancement of ACTA2 transcription in fibroblasts. 
These data suggested that the 33-bp sequence contains a cis-acting negative control 
element (104, 105). Interestingly, further analysis of this repressive sequence led to the 
identification of an activation sequence, CATTCCT (corresponding to bp -181 to -175), 
within the 3’ flanking region of this repressive element. The activation sequence had 
previously been described as an inverted muscle-CAT (MCAT) activation element (68, 
70).  
Although two MCAT motifs were identified in the ACTA2 promoter (bp -182 
through -176 and -320 through -314) and confirmed to govern ACTA2 activation, only the 
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proximal MCAT element (bp -182 through -176) possessed the ability to repress and 
activate ACTA2 (68, 103). Furthermore, Cogan et al evaluated the functional properties of 
the proximal MCAT element and flanking repressor sequence by mutating nucleotides 
within the purine-rich proximal MCAT enhancer element in the -195 to -164 bp region. 
These mutations inhibited binding of RTEF-1 to the proximal MCAT enhancer element 
confirming that the enhancer element is important for RTEF-1 mediated ACTA2 
activation (68). 
 In addition to identifying the interaction between TEF-1 and the inverted MCAT 
consensus sequence, Cogan et al identified two sequence-specific, ssDNA-binding 
proteins, dubbed vascular actin single-stranded binding factors 1 and 2 (VACssBF1 and 
VACssBF2), that interact with ssDNA sequence elements surrounding the MCAT 
enhancer (68). Nucleotide mutations within the MCAT enhancer abolished (R)TEF-1 
binding but had no effect on VACssBF protein binding. Moreover, mutations that 
diminished VACssBF2 did not alter transcriptional activation of ACTA2 (68, 70, 102). 
These results indicated that binding sites for VACssBF proteins are proximal to the TEF-
1 binding site and located within a unique asymmetric polypurine/polypyrimidine 
(pur/pyr) tract. Deletion of the (pur/pyr) tract surrounding the MCAT enhancer resulted 
in transcriptional activation of ACTA2 suggesting that pur/pyr sites confer transcriptional 
repression (70). Mutational analysis of the TEF-1 binding site and proximal sequences 
showed that VACssBF1 specifically interacts with the pyrimidine-rich strand while 
VACssBF2 exhibited specificity for the purine-rich strand. These results indicated that 
these trans-acting repressors may regulate transcriptional activation by altering the 
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conformation of the MCAT enhancer region by stabilizing ssDNA conformation to 
prevent binding of TEF-1, which specifically recognizes the double-stranded MCAT 
motif. 
Interaction of VACssBF1 and 2 with opposing strands of the double stranded 
MCAT enhancer motif (-194 to -165) prevents binding of TEF-1. To establish a 
biochemical basis for ssDNA site specificity and repressive capabilities of VACssBF1 
and VACssBF2, studies by Kelm et al evaluated binding of VACssBF proteins to MCAT 
enhancer elements located within a proximal element and a coding element of ACTA2 
(106). An intragenic sequence located 3’ proximally to intron 2 in the coding element 
(CE) of the ACTA2 gene encodes a GGAATG TEF-1 binding site identical to that found 
in the promoter element (PE). Both VACssBF proteins and TEF-1 showed highly specific 
interaction with the MCAT enhancer element located within the PE whereas only 
VACssBF2 interacts with the purine-rich strand of the MCAT enhancer within the CE. 
Cell-based promoter-reporter assays showed that substitution of the PE motif for the CE 
led to repression of transcriptional activity. Mutations within the CE of the chimeric 
promoter prevented VACssBF2 binding and de-repressed the promoter. Furthermore, 
transcription was rescued upon introduction of VACssBF2 mutations. Together these 
data suggested that VACssBF2 possesses ssDNA-binding activity independent of 
VACssBF1 and that VACssBF2 may disrupt the dsDNA conformation of the MCAT 
enhancer element to prevent binding of inducible activators. UV-crosslinking and 
electrophoretic mobility assays revealed that VACssBF1 is composed of a single ~52 
kDa polypeptide with specificity for the pyrimidine-rich strand of the repressor element. 
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Evaluation of the molecular weight and DNA-binding site screening identified 
VACssBF1 as MSY1 (mouse YB-1), a member of the Y-box family of DNA/RNA-
binding proteins. Southwestern blots and electrophoretic mobility of VACssBF2, on the 
other hand, displayed three molecular weight species consisting of a higher molecular 
weight species at 115 kDa and a doublet with bands around 44 kDa and 46 kDa. These 
results indicated that VACssBF2 consists of multiple peptides or is multimeric complex 
of two different proteins. Finally, interaction of VACssBF2 with the CE represses the 
transcriptional enhancer independent of VACssBF1 and the dsDNA transcriptional 
activator. The VACssBF2 exon recognition element was used to screen a mouse lung 
cDNA expression library. Two cDNA clones encoding purine rich element binding 
proteins A (Pur") and B (Pur!) were isolated (107).  
The human Y-box binding protein 1 (YB-1) and Pur" were originally identified 
as transcriptional regulatory proteins in other cellular contexts. YB-1 is a DNA-binding 
protein that interacts with the pyrimidine-rich strand of a Y-box sequence of the human 
DRA promoter within the major histocompatibility complex II gene (108, 109). This 
confirmed the observation that VACssBF1 exhibited a strong preference for pyrimidine-
rich DNA. Pur" (or HeLa Pur Factor) had been formerly identified as a protein that 
bound to an origin of DNA replication in the 5’-flanking region of the c-myc gene in 
HeLa cell nuclear extracts. This observation confirmed that Pur" specifically recognizes 
purine-rich ssDNA. Pur!, on the other hand, had no aforementioned function (110). 
Based on the data presented, it was predicted that recombinant Pur", Pur!, and 
MSY-1 form multimers that specifically interact with the PE MCAT enhancer element to 
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prevent interaction of TEF-1 with the MCAT enhancer. To test this, cell-based 
transfection assays were carried out with promoter-reporter constructs containing 
mutations that prevent binding of Pur", Pur!, or MSY1 to evaluate expression of the 
reporter gene (101). This study revealed that deletion of nucleotides (111) -194 through -
192 lead to a significant decrease in Pur protein binding and thereby reduced the effective 
repression of the MCAT enhancer located in the PE of the ACTA2 promoter. These 
results indicate that Pur" and Pur! have the capacity to prevent TEF-1 interaction with 
the MCAT enhancer leading to repression of ACTA2 transcription. 
Together these studies indicate that Pur protein mediated ACTA2 repression 
requires the nucleoprotein assembly of ssDNA-binding repressors at the cryptic MCAT 
enhancer motif to prevent ACTA2 activation by TEF-1. Pur" and Pur! interact with the 
purine-rich sense strand of the MCAT element as either homo- or heterodimers while 
MSY-1 binds to the pyrimidine-rich anti-sense strand of the MCAT element. The 
ssDNA-binding repressors may facilitate strand separation of the duplex DNA as a 
mechanism to deter TEF-1 binding since TEF-1 specifically binds dsDNA.  A mutational 
analysis was used to map nucleotides that mediate Pur protein binding within the cryptic 
MCAT enhancer of ACTA2. Cell based promoter-reporter assays were carried out with 
promoter-reporter constructs harboring mutations within the ACTA2 MCAT enhancer 
sequence to identify mutations that are essential for Pur protein mediated repression. A 
truncated construct, VSMP4 (spanning nts -191 to +48), exhibited unrestricted MCAT-
dependent enhancer activity. However, extension of the 5’-flanking region through the 
addition of just four nts (-195 to -192) was sufficient to reduce ACTA2 enhancer-
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promoter activity to basal levels indicating that the extended promoter created a better 
binding site for repressors (101). Transient transfection assays with promoter-reporter 
constructs TV187, TV189, and TV191 indicated that mutation of guanine nucleotides 
upstream of the TEF-1 binding MCAT site led to de-repression of the ACTA2 promoter-
reporter constructs. Additionally, promoter constructs incorporating nucleotide mutations 
3’ of the MCAT motif resulted in diminished repression. These results suggested that 
there are distinct repressor binding sites located both 3’ and 5’ of the TEF-1 binding site 
(68). To more accurately identify specific nts involved in nucleoprotein interaction, 
synthetic oligonucleotides containing the same mutations were evaluated in direct 
ssDNA-binding assays. Mutation of the sequence between -175 and -172, ACTG, directly 
3’ of the MCAT enhancer element resulted in a significant increase in Pur protein 
binding. Notably, Pur proteins bound an oligonucleotide encoding nts -196 to -164 
(PE32-F) with the highest affinity. Oligonucleotides lacking key purine-rich elements 
resulted in a significant loss in Pur protein ssDNA-binding affinity (112). These results 
pointed to two sequence elements on the 5’-side, GGGAGC, and the 3’-side, GGAAGA, 
of the core MCAT sequence that are essential for high affinity Pur protein interaction.  !
1.4.1 ALTERNATIVE MECHANISMS OF PUR PROTEIN TRANSCRIPTIONAL 
REGULATION 
 
In addition to Pur! repression of ACTA2 transcription through interactions with 
the cryptic MCAT enhancer, the participation of Pur! in other ACTA2 regulatory 
pathways has been noted. The ACTA2 activators, Sp1 and Sp3, interact with the THR 
 20 
element and the TCE binding site in the SPUR element to stimulate SM"A expression. 
Conversely, interaction of Pur proteins with Sp1 bound to the TCE binding site generates 
a nucleoprotein complex that restricts the ability of Sp1 to activate SM"A expression 
(73, 76). During TGF!1 mediated ACTA2 activation, repressor proteins Pur" and Pur! 
are released from the SPUR element. This de-repression releases the inhibitory complex 
formed when Pur proteins interact with Sp1/Sp3 at the TCE element and activates ACTA2 
expression in fibroblasts (73, 76).!Although these alternative mechanism of Pur protein-
dependent ACTA2 regulation will not be discussed at length in this literature review, it is 
important to note that structural characterization of Pur" and Pur! will be essential for 
understanding the structural elements in each protein that facilitate direct Pur repressor 
interaction with specific trans-activators. 
 
1.5 DIVERSE CELLULAR FUNCTIONS FOR PUR PROTEINS 
The mammalian Pur protein family consists of four highly homologous proteins; 
Pur", Pur!, Pur$A and Pur$B that interact with purine-rich ssDNA and RNA. The two 
isoforms of Pur$ result from differences in polyadenylation (113). Although ubiquitously 
expressed in metazoans, little is known about the function of the Pur$ isoforms (114). 
Pur" is a ubiquitous regulatory factor that participates in numerous cellular processes 
whereas Pur! appears to participate in specific regulatory tasks associated with 
repression of the ACTA2 gene and modulation of cell differentiation. The functional 
properties of Pur proteins in other cellular systems shape our understanding of Pur 
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protein function and provide a foundation for evaluating Pur proteins in the context of 
SM"A gene expression.  
 
1.5.1 PUR PROTEIN INVOLVEMENT IN REPLICATION PATHWAYS 
 
Human Pur" was originally identified in HeLa cells as a ssDNA-binding factor 
that interacted with a purine-rich consensus sequence upstream of the c-myc promoter 
during replication (110, 115). Due to the fact that Pur" exhibits specificity for purine-rich 
sequences, the consensus binding sequence was originally termed the purine-rich (PUR) 
element (110, 115). Competitive electrophoretic mobility assays pointed to a 24mer 
ssDNA oligonucleotide derived from the replication origin of c-myc, MF0677 (5’-
GGAGGTGGTGGAGGGAGAGAAAAG-3’) that exhibited a band shift induced by the 
presence of Pur". This Pur"-MF0677 interaction was confirmed by UV-irradiation 
crosslinking studies that covalently linked Pur" to MF0677 in HeLa cell nuclear extracts. 
Methylation of guanine residues or guanine to adenine mutations analyzed by 
footprinting analyses detected guanine specific protein contacts between Pur" and 
MF0677. (110). Screening of the GenBank nucleotide sequence database identified 
numerous sequences from DNA replication zones homologous with the PUR element. 
Specifically, a 16 nt sequence was conserved across 12 ori zone sequences from various 
eukaryotic organisms and termed the PUR consensus sequence element 
(GGNNGAGGGAGARRRR-3’, N is any nucleotide, R is A or G). These findings 
suggested that Pur" may play a key role in initiation of DNA replication.   
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In a follow up study, Bergmann et al analyzed the ability of Pur" to bind mutants 
of the MF0677 oligonucleotide (110, 115). The effect of incremental substitution of 
thymine nts for nts within MF0677 was evaluated using competitive binding reactions 
resolved by gel shift assays. Competitive binding was retained in an oligonucleotide 
(MH0677) that encoded the sequence, GGAGGG, while alteration of this sequence in 
oligonucleotide ME0677 resulted in diminished binding capacity. These results suggest 
that GGAGGG is the minimal sequence element required for Pur" ssDNA-binding. 
Additionally, GGT repeats at the 5’-end of MF0677 appear to be important for protein 
contact whereas adenine nts in the 3’-end of MF0677 (MC0677) have little effect on 
nucleoprotein complex formation. These results were consistent with methylation 
interference studies that pointed to the importance of guanine but not adenine nts in 
ssDNA binding.  
Pur" has also been reported to play a role in viral genome replication of the JC 
polyoma virus (HJCV) as a regulator of the lytic cycle. Pur" and YB-1 exhibit opposing 
functions to govern lysogeny of HJCV under the control of the JC tumor antigen. Band-
shift assays evaluating binding of Pur", YB-1, and HJCV T-antigen (Tag) indicated that 
interaction of Pur" with the viral lytic control element of the HJCV promoter activates 
early gene transcription to sustain lysogeny (116). Conversely, YB-1 acts as an antagonist 
of Pur" and disrupts the Pur":HJCV promoter nucleoprotein complex by binding to the 
opposite strand of the cognate binding site facilitating expression of late genes triggering 
the lytic cycle (117). Interestingly, the effect of Pur" binding is reversed in patients 
infected with HIV. In this context, late transcriptional activation of the JCV Tat-
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responsive transcriptional control element is mediated by internalization of exogenous 
Tat into oligodendroglia followed by association with Pur" (118, 119). Formation of a 
Tat/Pur" complex allows for association of the complex with a Pur" binding site 
(GGAGGCGGAGGC) within a Tat-responsive JCV element, upTAR (118, 119). This 
synergistic activation of the JCV late genes stimulates viral replication without the co-
infection of both HJCV and HIV-1 in cells (120, 121). 
These studies suggest that Pur" participates in a variety of cellular contexts 
involved in genomic replication. Pur" acts as a regulatory factor in these pathways not 
only through direct interactions with DNA but also through protein-protein interaction. 
Furthermore, initial studies identified a PUR consensus sequence, 5’-GGGAGA-3’, 
within the MF0677 sequence that has become a standard oligonucleotide for testing Pur 
protein ssDNA-binding (110, 115, 122-124). Although both Pur" and Pur! have the 
capacity to interact with the PUR consensus sequence, the sequence only binds one mole 
of Pur" or Pur!. As described earlier, the ACTA2-derived MCAT enhancer sequence, 
PE32-F, contains two flanking sequences that are essential for high-affinity Pur! ssDNA-
binding (112). Both Pur protein binding sites of PE32-F resemble the single consensus 
sequence identified in c-myc. These studies indicate that a single PUR consensus site is 
sufficient to trigger c-myc replication, but transcriptional repression of the cryptic MCAT 
enhancer may require the binding of two Pur proteins to prohibit interaction of TEF-1. A 
recent study by Ramsey et al. validated this supposition by reporting that two Pur! 
monomers interact with PE32-F in a cooperative manner forming a 2:1 Pur!:PE32-F 
nucleoprotein complex with high-affinity (125). Therefore, although the PUR consensus 
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element is employed as a standard for evaluating Pur protein binding, in the context of 
ACTA2 transcriptional regulation, PE32-F is a more suitable ssDNA probe for testing Pur 
protein interaction with the MCAT enhancer region of ACTA2. 
 
1.5.2 PUR PROTEIN INVOLVEMENT IN TRANSCRIPTIONAL REGULATION  
 
Pur" is key transcriptional regulatory factor for many genes. In addition to acting 
as a repressor of ACTA2 transcription, the involvement of Pur" in the transcriptional 
repression of somatostatin ssCRE and "-myosin has been noted. Additionally, Pur" 
participates in regulatory pathways of transcriptional activation. During neuronal 
development, Pur" regulates the expression of the myelin basic protein (MBP) gene in 
glial cells (126). The proximal promoter of the MBP gene contains a Pur" GC/GA-rich 
binding site (dubbed MB1) that is required for Pur" mediated transcriptional activation 
of MBP expression (127-130). The expression of MBP varies with different stages of 
brain development (129, 130).  
The involvement of Pur proteins in regulation of replication and transcription 
brings to question the mechanism by which Pur proteins access cognate binding sites. Pur 
proteins are sequence-specific transcriptional regulators that preferentially bind single-
stranded nucleic acid. Presumably, Pur proteins would have a low affinity for the 
supercoiled and duplex genome. Despite the apparent inconsistency between Pur protein 
sequence specificity and the duplex conformation of the genome, they achieve access to 
ssDNA and regulate gene promoter sequences. Two mechanisms have been proposed that 
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would allow Pur proteins to access the duplex genome (65, 124, 131). First, natural 
perturbations within the DNA duplex may be facilitated by non-B-form DNA structures 
or other transcription factors that facilitate localized dsDNA melting. The formation of 
secondary structure in nucleic acids is common at transcriptionally active sites. Non-B-
form duplex DNA structures such as Z-DNA, G-quadruplexes, and cruciforms are 
frequently identified within gene promoter regions (132, 133). In fact, Strauch et al.  
proposed a cruciform stem-loop structure for the MCAT/THR cis-elements of the ACTA2 
promoter (65). Additionally, non B-form DNA secondary structures are commonly 
identified in asymmetric duplex DNA sequences such as the pur/pyr asymmetry 
surrounding the cryptic MCAT enhancer motif (134, 135). Pur proteins exhibit a 
preference for purine-rich stretches of ssDNA supporting the idea that localized melting 
of complementary strands of genomic DNA may contribute to Pur protein induced helix 
destabilization. 
The second mechanism that has been proposed for Pur protein helix 
destabilization is one by which Pur proteins facilitate duplex DNA unwinding. In support 
of this hypothesis, multiple studies have reported interaction of Pur" with dsDNA 
probes. A report by Wortman et al. indicated that Pur" has the ability to unwind DNA 
duplexes of various lengths in an ATP independent manner (124). The interaction of 
Pur" with supercoiled pUC19 plasmids produced distinct bands indicative of unwinding 
of the DNA duplex (124, 131). The banding pattern observed in these electrophoretic 
mobility shift assays (EMSAs) was comparable to that achieved after treatment of 
supercoiled plasmids with topoisomerases. A similar pattern was observed when 
 26 
experiments were performed with a pUC19 plasmid containing the c-myc-associated 
replication origin. These results indicate that interaction of Pur" with the pUC19 plasmid 
may lead to an increase in twist or writhe to facilitate DNA backbone opening around the 
Pur" binding site.  
 
1.5.3 PUR PROTEIN INVOLVEMENT IN PROTEIN-PROTEIN 
INTERACTIONS 
 
Pur" also participates in protein-protein interactions that are critical for gene 
replication and transcription. As mentioned previously, interaction between the HJCV T-
antigen and Pur" regulates lytic cycle gene expression. Furthermore, the HIV-1 Tat 
protein interacts with Pur" to facilitate JCV late gene activation (119, 136). Pur" also 
plays a critical role in cell cycle control by forming protein-protein complexes with key 
cell cycle regulatory proteins. Overexpression of Pur" in an NIH-3T3 cell line arrests the 
cell cycle at the G1/S check point phases (137). Pur" has been shown to interact with the 
retinoblastoma protein (pRb) tumor suppressor via a psycho motif located in the C-
terminus of Pur" (115, 138).  
In addition, the formation of transcriptional repressor complexes at sequences 
composed of GGN repeats (N is any nucleotide) often depends on protein-protein 
interactions between multiple transcription factors including Pur" and Pur!. For 
example, a multimeric complex of Pur!, Pur", and Sp3 has been shown to repress !-
myosin heavy chain (!MyHC) expression in skeletal muscle (139). Formation of 
multimeric protein complexes as a mode for controlling intracellular processes is distinct 
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from other modes of genomic regulation since it does not require the association of Pur 
proteins with cis-regulatory elements. This indicates that Pur proteins possess structural 
elements that mediate protein-protein interaction as well as ssDNA-binding to specific 
sequences within genomic DNA. Furthermore, recent studies indicate that Pur! possesses 
the capability to reversibly self-associate in the absence of nucleic acid and to assemble 
onto the MCAT enhancer motif of the ACTA2 gene via a cooperative binding mechanism 
(125).  
 
1.5.4 PUR PROTEIN INVOLVEMENT IN mRNA TRANSPORT 
 
Pur proteins have been documented to interact with specific mRNAs as a 
mechanism for regulating expression of mRNA transcripts at a translational level. Both 
Pur" and Pur! have been reported to repress the cytoplasmic translation of the mRNA 
transcript encoding cardiac "-myosin heavy chain ("-MHC) (140, 141).  Pur proteins 
also interact with other mRNA targets to facilitate translational regulation, nuclear 
export, and cytoplasmic transfer involved in neuronal development (142).  
Neuronal development requires transport of RNA:protein complexes (RNPs) 
along dendritic microtubules for localized translation of mRNAs. Several RNA 
transcripts including microtubule associated protein (MAP) and RNA polymerase III-
transcribed RNA (BC1 RNA) have been identified in the neuronal postsynaptic 
compartments. Both Pur" and Pur! have been identified in nucleoprotein complex with 
BC1 RNA as BC1 RNP and act as a connection between BC1 RNA and the microtubule 
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that transports the complex and distributes it throughout neuronal dendrites (143). A Pur" 
deficient transgenic mouse (PURA-/-) generated by inactivation of the PURA gene led to 
the defective brain development and perinatal lethality (142). The neurological 
complications associated with abolishment of Pur" expression are likely to be associated 
with the lack of Pur" available to transport mRNA to developing dendrites.  
As described above, Pur proteins participate in numerous cellular processes 
including replication, transcriptional regulation, multi-protein complex formation, and 
mRNA binding to regulate at the translational level as well as transport of mRNA 
transcripts. Despite ~70% identity between Pur" and Pur!, Pur" appears to be 
considerably more ubiquitous and contribute to numerous cellular pathways. The role of 
the Pur! isoform, on the other hand, is as a dominant repressor of ACTA2 and other genes 
encoding muscle-specific isoforms of actin and myosin.  
 
1.6 STRUCTURAL CHARACTERIZATION OF PUR PROTEINS 
Until recently, published data on the structural make-up of Pur! was limited to 
the primary sequence, secondary structural predictions, and quaternary structure (107, 
144, 145). This section will review the structural characteristics of Pur proteins identified 
in early studies and elaborate on recent developments that inform our current 
understanding of Pur protein structure and function. Finally, differences between the Pur 
isoforms and limitations of the current data on Pur protein structure will be discussed.  
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1.6.1 PRIMARY STRUCTURE OF PUR PROTEINS 
 
A clone of Pur" was isolated and the primary sequence was determined by 
Bergmann et al (110). These experiments suggested that the cDNA-deduced amino acid 
sequence of Pur" was unique in comparison to all other proteins that had been sequenced 
at that time. To date, the primary sequences of Pur proteins from numerous organisms 
have been identified by gene cloning and DNA sequence analysis. Alignment of the 
primary amino acid sequence of Pur! and Pur" from various vertebrate species reveals a 
high sequence homology across organisms (Figure 1-2). The high homology across Pur 
proteins indicates that Pur" and Pur! probably share a common ancestral gene that 
underwent duplication and divergence resulting in the existence of Pur protein paralogs. 
Mouse Pur" and Pur! are approximately 70% identical due to the high sequence 
conservation of the central core region of each protein are essential for Pur protein 
function. The presence of glycine-rich amino acid sequences within the central modular 
region and near the C-terminus are unique features of the Pur! paralog. Polyglycine 
sequences have been implicated in helix destabilization of other DNA-binding proteins 
such as FBP in the c-myc promoter (146). Consequently, these glycine-rich stretches may 
impart unique functional properties to Pur!. The Pur protein sequence is composed of a 
modular central domain surrounded by glycine-rich N- and C-termini. The central region 
is highly conserved in all Pur paralogs and is made up of alternating sequence motifs that 
fall into one of two classes and possess a high level of sequence homology. Class one 
repeats are made up of basic and aromatic amino acid residues (mostly Phe and Tyr). On 
the other hand, class II repeats consist of amino acid stretches rich in leucine and acidic 
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amino acids (Figure 1-3). This modular distribution of amino acids has led to the 
prediction that basic amino acids in the class I motif may mediate electrostatic 
interactions with the negatively charged phosphate backbone of nucleic acids and 
aromatic residues might participate in base-stacking interactions. Additionally, a unique 
sequence, dubbed the psycho motif, is located at the C-terminal end of the central domain 
and is composed of Pro-Ser-Tyr with a downstream Cys residue (138). The psycho motif 
is similar to sequence motifs found in cell cycle regulatory proteins and mediates 
interaction with the transcription factors pRb and E2F-1 and the large T-antigen of the 
simian virus 40 (SV40) (122, 131). It was suggested that this psycho motif might form an 
amphipathic helix (110). The psycho motif is essential for Pur" interaction with pRb 
(122). Finally, the C-termini of Pur" and Pur! are markedly different. The Pur! C-
terminus is rich in glutamate (E) and glycine (G) residues but the Pur" C-terminus 
contains a polyglutamine (Q) sequence that replaces glycine residues found in Pur!.  
A collection of data from multiple studies evaluating the effect of Pur protein 
deletion mutants on single-stranded nucleic acid binding provides insight into the 
function of Pur protein sequence elements and their role in sequence-specific ssDNA-
binding to purine nts. The core region of human Pur" containing all Pur repeats (amino 
acids 65-191) is critical for association with the c-myc origin of replication (124), the 
HJCV control element (116), the MBP promoter sequence (130), and somatostatin and 
tyrosine hydroxylase cAMP response elements (CREs)  
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Figure 1- 2. Primary sequence alignment of Pur" and Pur! from different species. 
Alignment of the primary sequence of Homo sapiens (Human), Mus musculus (Mouse), 
Rattus norvegicus (Rat), and Drosophila melanogaster (Fruit Fly) Pur" and Pur!. Amino 
acid sequences were aligned and obtained using the UniProt database (147). The three 
regions of high sequence homology (dark gray) are separated by amino acid stretches of 
low sequence conservation (light grey). 
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!
Figure 1- 3.The primary structure of Pur" and Pur! is composed of three PUR repeats 
flanked by N- and C-terminal tails. Both PUR repeat I and PUR repeat II consist of one 
module composed of basic and aromatic amino acid residues (dark blue) and a portion of 
the module containing leucine and acidic amino acid residues (dark red). Instead of an 
acidic/leucine-rich module (red), the PUR III repeat contains a psycho motif (purple). 




(148). Deletion of the C-terminal tail of Pur" (amino acids (aa) 215-322) impairs dsDNA 
binding (124). In addition, elimination of the C-terminus (aa 264-324) of Pur! diminishes 
the capacity of Pur! to repress activation of an ACTA2-derived MCAT enhancer element 
(149) and prevents protein-protein interactions of Pur! with Pur" and co-repressor 
MSY1 (69). These results suggest that the core sequence of Pur proteins is essential for 
interaction with nucleic acids and the C-terminal tail plays a regulatory role in DNA 
binding.  
More recently, an x-ray crystal structure of Drosophila melanogaster (61) Pur" 
amino acids 40 through 185 prompted re-evaluation of the original domain assignments 
and the proposal of a new scheme to identify modular sequence elements in Pur proteins 
based on the PUR domains delineated by the crystal structure. In this schematic, the 
central sequence is composed of three PUR repeats. PUR repeats I and II are each 
composed of one class I repeat and a segment of one class II module while Pur repeat III 
consists of one class I module and the psycho motif (150).  
 
1.6.2 SECONDARY STRUCTURE OF PUR PROTEINS 
 
In the absence of higher order structural data, predictions regarding Pur protein 
secondary structural elements were made using protein structure prediction webservers 
(151). These programs were used to determine the propensity of protein sequences to 
form secondary structural elements such as "-helix, !-strand, random coil, or other 
secondary structural elements. Based on the sequence of Pur!, programs predicted that 
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each PUR repeat consists of three or four !-sheets and one "-helix (Figure 1-4). The 
PUR III repeat containing the psycho motif is predicted to encode an extended " -helix. 
A recently solved x-ray crystal structure of Dm Pur" residues 40-185 confirmed these 
secondary structural predictions for the first two PUR repeats (150). The structure 
revealed that each PUR repeat consists of a C-terminal "-helix and four-antiparallel !-
sheets. PUR repeats I and II are linked by a short random coil and form a PUR 
subdomain with a !!!!"-!!!!" topology. The high resolution structure of the PUR 
repeat III has yet to be established.  
 
1.6.3 TERTIARY STRUCTURE OF PUR PROTEINS 
 
For many years, the tertiary structure of Pur proteins was limited to speculation 
based on the primary sequence.!Graebsch et al. sought to identify the key sequences 
elements conserved in Pur" proteins (150, 152). Using homology detection, they 
identified a bacterial protein that consisted of a single PUR repeat, which self-associated 
with another PUR repeat to form an intermolecular PUR domain (152). The recently 
solved x-ray crystal structure of Dm Pur" residues 40-185 spanning PUR repeats I and II 
constituted a monomeric PUR subdomain (150). The structure revealed that PUR repeats 
I and II interact to form a PUR subdomain with each PUR repeat consisting of a C-
terminal alpha helix and four antiparallel !-strands. PUR repeats I and II are linked by a 





Figure 1- 4. Secondary structural predictions based on the Pur! amino acid sequence 
indicate a repetitive sequence of !-strands (yellow arrow) and "-helices (pink) separated 
by a random coil (black line). The secondary structural predictions were obtained using 
PsiPred (151). The mouse Pur! sequence was obtained from UniProt (147).  
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hydrophobic residues buried at the interface between the two PUR repeats. A surface 
conservation plot of Pur" I-II indicates a high level of conservation localized around the 
!-sheet side while the "-helix side was void of conserved residues. Additionally, 
electrostatic surface maps revealed localization of positively charged residues around the 
!-sheets, whereas the "-helices displayed a slightly negative charge. The regions of 
positively charged residues represent potential binding sites for negatively charged 
nucleic acids. Pur" I-II retained the ability to associate with the PUR consensus element 
(150). 
The PUR domain is structurally homologous to the whirly-class nucleic-acid 
binding fold. Other whirly-domain containing proteins with the !!!!"-!!!!" topology 
include RNA-binding proteins, mitochondrial RNA-binding protein (MRP)-2 and MRP-1 
(153), and a DNA-binding protein, P24 (154). Superposition of whirly domains from 
Pur" with those from P24, MRP-1 and -2, revealed a common overall topology. The 
PUR whirly-like domains exhibited longer random coil loop regions and a slightly tilted 
!-sheet orientation relative to MRP2. Although most whirly domain-containing proteins 
exhibit a tetrameric quaternary structure whereby protein-protein contacts form between 
"-helices, no protein-protein contact was observed in the Pur" I-II crystal lattice (150). 
 
1.6.4 QUATERNARY STRUCTURE OF PUR PROTEINS 
 
The quaternary structure of Pur! has been elucidated by hydrodynamic and 
thermodynamic techniques. To evaluate the quaternary structure of solution-phase 
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recombinant Pur!, Ramsey et al. used dynamic light scattering coupled to size exclusion 
chromatography (SEC) to show that Pur! has the capacity to self-associate and form a 
concentration dependent homodimer in the absence of nucleic acid (145). Dynamic light 
scattering experiments and resolution of the hydrodynamic radius indicated that Pur! 
takes on an asymmetric, non-spherical shape. Further results using analytical 
ultracentrifugation showed that Pur!, free of nucleic acid, exists in a reversible 
equilibrium between the monomeric and dimeric state with a dissociation constant of ~1 
µM. The concentration dependent reversible nature of Pur! dimerization may play a 
significant role in nucleic acid binding and ultimately modulation of ACTA2 expression.  
Further studies analyzing the mechanism and energetics involved in Pur! 
assembly on the purine-rich strand of the cryptic MCAT enhancer element of the ACTA2 
promoter revealed the formation of a high affinity nucleoprotein complex with a 2:1 
(Pur!:PE32-F) stoichiometry (125). Results of quantitative band shift and DNase I 
footprinting assays were consistent with a model in which Pur! monomers interact in a 
sequential and cooperative manner with two non-identical sites to form the 2:1 
protein:ssDNA complex. The apparent affinity of the Pur! for PE32-F was determined to 
be approximately 0.3 nM.  
 
1.6.5 POINT MUTATIONS OF INDIVIDUAL PUR PROTEIN AMINO ACIDS 
 
Several studies have identified amino acid residues in the Pur proteins that 
mediate nucleoprotein interaction. An initial study by Wortman et al. identified point 
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mutations that significantly diminished ssDNA binding in mouse and human Pur" (124). 
Mutation of basic residues in the PUR I-II subdomain of Pur", R71E and R110E, greatly 
diminished Pur" ssDNA-binding. Knapp et al. generated the corresponding mutations in 
the Pur! isoform and evaluated the effect of these mutations on repression of ACTA2, 
functional ssDNA-binding, and protein folding (144). Although these mutations 
generated a Pur! protein defective in ssDNA interaction, the mutations also resulted in 
destabilization of the secondary, tertiary, and quaternary structure of Pur!. Studies 
revealed the formation of oligomeric complexes with a lower percent of helical secondary 
structural elements suggesting that the loss in nucleic acid binding was likely due to a 
loss in structural stability. 
As stated above, Pur proteins play a role in nuclear RNA export and formation of 
mRNP transport granules in neuronal cells. A recent study by Aumiller et al. evaluated 
the localization of Dm Pur" during oogenesis, a cellular process that requires transport of 
mRNP granules (142). Co-immunoprecipitation experiments showed that Pur" interacts 
with many different RNAs and plays an important role in oocyte mRNA transport 
between the nucleus and cytoplasm via the oocyte mRNA transport system. In addition, 
this study identified three amino acids in Pur" that are critical for mRNA binding. 
Mutation of residues R80A/R158A/R229A abolished single-stranded nucleic acid 
binding but did not impact conformational stability or dimerization of Pur". These results 
suggested that amino acid residues R80, R158, and R229 are critical for contacting 
single-stranded nucleic acids and forming a nucleoprotein complex in the context of 
mRNP formation.  
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In summary, the level of SM"A expression directly correlates with myofibroblast 
phenotype and modulation of myofibroblast differentiation. Pur! is the dominant 
transcriptional repressor of SM"A expression in muscle-specific cell types. Therefore, 
elucidation of the mechanism by which Pur! associates with the purine-rich strand of the 
MCAT enhancer element of ACTA2 is essential for understanding the factors that govern 
SM"A expression. Determination of a structural basis for ssDNA-binding of Pur! to the 
MCAT enhancer may point to potential therapeutic strategies for treating fibrotic disease.  
Although Pur" and Pur! possess 70% sequence identity, numerous studies 
indicate that these Pur protein isoforms exhibit distinct functional properties. First, Pur" 
is ubiquitously involved in replication, transcriptional repression, transcriptional 
activation, formation of multimeric protein complexes, and mRNA transport, whereas 
Pur! is almost exclusively involved in transcriptional repression of muscle-related genes. 
Furthermore, dimerization of two Pur" monomers requires an RNA molecule (155) while 
self-association of Pur! monomers occurs in the absence of nucleic acid (145). This 
mechanistic difference in Pur protein self-assembly may be due to the fact that Pur! and 
Pur" have distinct functional properties. In addition, Pur! has been identified as the 
dominant repressor of ACTA2 activation in myofibroblasts, vascular SMCs, and 
cardiomyocytes (112, 144). The expression of Pur! and Pur$ in the Pur" knockout mouse 
(PURA-/-) did not rescue postnatal brain development (156). These observations along 
with Pur protein gain-of-function studies indicating that structural and functional 
characteristics are not equivalent in all Pur paralogs (112, 149) point to key structural and 
functional differences between the Pur! and Pur" homologs. These studies highlight the 
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importance of studying the independent structural features associated with each Pur 
protein. 
Duplex DNA helix destabilization resulting in the formation of locally unwound 
ssDNA sites in asymmetric pur/pyr tracts in the 5’-ACTA2 promoter has warranted 
investigation into the ssDNA-binding mechanism of Pur proteins (157). Nucleoprotein 
complex formation at PUR elements has identified both homo- and heterodimers of Pur 
proteins (69). Recent studies have indicated that Pur! employs a cooperative binding 
mechanism to interact with the MCAT enhancer motif. The elements that facilitate Pur 
proteins nucleoprotein complex formation with the PUR elements require further 
investigation. In this study, we establish a structural basis for Pur! mediated ACTA2 
repression and cooperative ssDNA-binding to the ACTA2-derived MCAT enhancer 
element sequence. 
Pur! plays an important role in regulation of ACTA2 gene transcription. Higher 
order structural data regarding the organization of Pur! is limited to the primary 
sequence, secondary structure predictions, and quaternary structure. Herein, we have 
evaluated the structural elements of Pur! that confer site-specific ssDNA-binding to the 
cryptic MCAT enhancer motif. The first aim was to characterize the physical and 
functional roles of the intra- and intermolecular domains of Pur! in ACTA2 repression 
and site-specific ssDNA-binding. As a second aim, we sought to identify amino acid 
residues that confer specificity and high-affinity binding of Pur! to ssDNA target sites 
within the ACTA2 promoter. We propose that Pur! is composed of a core ssDNA-binding 
domain with a tripartite organization that forms intra- and intermolecular subdomains that 
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mediate nucleoprotein formation and facilitate ACTA2 repression. Furthermore, we have 
found that these subdomains contain basic amino acid residues that mediate ACTA2 
repression in MEFs. The elucidation of structural elements that facilitate nucleoprotein 
complex formation between Pur! and the MCAT enhancer sequences will improve our 
understanding of the structural mechanism by which Pur! mediates SM"A gene 
repression. These findings may have therapeutic implications for regulating 
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Pur! is a single-stranded nucleic acid-binding protein implicated in the injury-
induced repression of genes encoding certain muscle-restricted isoforms of actin and 
myosin expressed in the heart, skeletal muscle, and vasculature. To better understand 
how the modular arrangement of the primary sequence of Pur! affects the higher order 
structure and function of the protein, purified recombinant Pur! was subjected to partial 
proteolysis in an attempt to identify a well-folded truncation protein that retained purine-
rich single-stranded DNA-binding activity. Limited tryptic digestion of Pur! liberated a 
core ~30 kDa fragment corresponding to residues 29-305 as determined by epitope 
mapping and mass spectrometry. Size exclusion chromatography indicated that the 
isolated core fragment retains the ability to self-associate while circular dichroism 
analysis confirmed that the Pur! core domain is stably folded in the absence of glycine-
rich N- and C-terminal sequences. Comparative DNA-binding assays revealed that the 
isolated core domain interacts with purine-rich cis-elements from the smooth muscle "-
actin gene with similar specificity but increased affinity compared to full-length Pur!. 
These findings suggest that the highly conserved modular repeats of Pur! fold to form a 
core functional domain, which mediates the specific and high affinity binding of the 
protein to single-stranded DNA.  
 62 
INTRODUCTION 
Purine-rich element binding protein B (Pur!) is a member of a small but highly 
conserved family of nucleic acid-binding proteins whose signature biochemical feature is 
preferential interaction with purine-rich single-stranded DNA (ssDNA) or RNA 
sequences (1). The founding and most widely studied member of this family, Pur", is 
involved in many aspects of nucleic acid homeostasis including the regulation of DNA 
replication, DNA repair, gene transcription, RNA transport, and mRNA translation (2,3). 
With respect to gene expression, an ensemble of reports have implicated both Pur" and 
Pur! in the repression of genes encoding smooth, cardiac, and skeletal muscle-associated 
isoforms of actin and/or myosin in stress-activated fibroblasts, smooth muscle cells, 
cardiomyocytes, and skeletal myoblasts (4-7). The key biochemical finding shared by 
these muscle-related studies is the sequence- and strand-specific interaction of Pur" and 
Pur! with GGN repeat-containing cis-elements. In the case of the gene encoding smooth 
muscle "-actin (SM"A), Pur" and Pur! appear to repress transcription by ssDNA-
binding and protein-protein interaction mechanisms that limit access of trans-activators 
to canonical double-stranded DNA (dsDNA) target sites in the SM"A 5´-flanking region 
(4,5,8).  
Despite the fact that Pur" and Pur! are highly homologous (9) and exhibit 
comparable ssDNA-binding properties in vitro (10), these proteins are not entirely 
redundant in terms of their transcriptional regulatory properties toward specific muscle 
genes in different cell types. For example, Pur! displays substantially more repressor 
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activity toward the SM"A promoter than Pur" when over-expressed in cultured vascular 
smooth muscle cells (11). Moreover, gene knockdown and chromatin 
immunoprecipitation analyses have pointed to endogenously-expressed Pur! as the more 
crucial player in SM"A gene repression in mouse embryonic fibroblasts (12,13). A 
unique role for Pur! in actin and myosin isoform class switching has also been suggested 
in the context of cardiac transplant remodeling, heart failure, and skeletal muscle 
performance (14-16). Biochemical explanations for the seemingly dominant repressor 
activity of Pur! have included its preferred binding to certain trans-activators (12) and its 
ability to interact cooperatively with multiple ssDNA-binding sites (17).  
Published data on the molecular architecture of Pur! is currently limited to aspects of 
primary, secondary, and quaternary structure (9,13,18). The primary sequence of Pur! is 
characterized by alternating basic/aromatic class I and acidic/leucine-rich class II 
modules which are highly conserved in Pur" (9) and all other known members of the Pur 
protein family in mammals (1,3). The recently solved x-ray crystal structure of residues 
40 to 185 of Drosophila melanogaster (56) Pur" has revealed that the first and second 
class I and II modules fold into two homologous PUR repeats each with !!!!" topology 
(19). Moreover, intramolecular interaction between the "-helices of the two PUR repeats 
forms a ssDNA-binding domain resembling the Whirly class of nucleic acid-binding 
proteins (19). The case for Pur! adopting a similar core structure is supported by 
sequence homology (9) and site-directed mutagenesis studies indicating that certain 
amino acids within this region are critical to the conformational stability and functional 
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activity of the protein (13). However, Pur! does possess some unique features including 
two internal glycine/proline-rich stretches, which interrupt the second PUR repeat, and 
other distinguishing sequence elements near the N- or C-terminal regions of the protein, 
which may serve to modulate its ssDNA-binding function (10,11). In this study, we 
utilized limited proteolysis to probe the structure of recombinant mouse Pur! in solution 
and to identify a well-folded core domain that mediates specific and high affinity binding 
of Pur! to ssDNA.  
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MATERIAL AND METHODS 
Recombinant Pur!  purification. Full-length mouse Pur! was expressed in E. coli as 
an N-terminal 6%His-tagged fusion protein and purified by metal chelate affinity and 
calibrated size exclusion chromatography (SEC) (18). Protein purity was assessed by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing 
conditions and staining with Coomassie& Brilliant Blue R-250. Absence of nucleic acid 
in NHis-Pur! preparations was confirmed by determining the A260/A280 ratio. Protein 
concentration was calculated based on theoretical molar extinction coefficient for NHis-
Pur! at 280 nm of 20,400 M#1 cm#1. 
Proteolytic resistance assay. Limited digestion reactions were initiated by the 
addition of either sequencing- or proteomics-grade trypsin (Roche Applied Science or 
Sigma-Aldrich) to 3.0 or 5.0 µM solutions of NHis-Pur! at 4°C in buffer consisting of 50 
mM sodium phosphate pH 7.5, 300 mM NaCl, 0.5 mM EDTA, and 10 mM !-
mercaptoethanol (!-ME). Pur! to enzyme mass ratios were tested at 10:1 and 25:1. 
Aliquots were removed at 0, 15, 30, 60, 90, or 120 min time points, supplemented with 
1% w/v SDS and 5% v/v !-ME, and heated at 95oC for 5 min. Protein fragments were 
separated by SDS-PAGE (12% or 10% mini-gel) and visualized by Coomassie& Brilliant 
Blue R-250 staining. Alternatively, fragments were transferred to a polyvinylidine 
fluoride (PVDF) membrane (Immobilon'-P, Millipore) and probed with polyclonal 
antibodies against selected Pur! sequences (4), a monoclonal antibody against the N-
terminal RGS(H)6 tag (Qiagen), or biotinylated ssDNA (Supplementary Methods). 
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Prestained markers (New England Biolabs or Invitrogen) were used as molecular weight 
standards on western and southwestern blots. Wide range SigmaMarker' standards 
(Sigma-Aldrich) were used on stained gels.  
Purification of the Pur!  core tryptic fragment. A 1 mg/ml solution of NHis-Pur! 
was combined with proteomics grade trypsin at a protein to enzyme ratio of 500:1. After 
incubating for 6 h on ice, N"-tosyl-lysine-chloromethylketone and benzamidine were 
sequentially added to a final concentration of 0.1 mM and 10 mM, respectively. Insoluble 
material was removed by centrifugation at 2,500 % g for 5 min and the soluble digest was 
applied to a small column packed with ~2 ml heparin-agarose (Sigma-Aldrich) 
equilibrated with 20 mM Tris-Cl pH 7.4, 300 mM NaCl, 0.5 mM EDTA, 0.1 mM 
benzamidine, 0.1 mM phenylmethanesulfonylfluoride, and 10 mM !-ME. Bound protein 
was eluted by applying a linear gradient of 0.3 M to 2.0 M NaCl in column equilibration 
buffer. Individual fractions were analyzed by SDS-PAGE to identify those enriched in 
the core fragment. The concentration of the core fragment in pooled fractions was 
calculated assuming a molar extinction coefficient at 280 nm of 20,400 M#1 cm#1.  
Circular dichroism spectroscopy. Purified NHis-Pur! or the core fragment were 
dialyzed into buffers consisting of 10 mM Tris-Cl pH 7.5, 150 mM NaCl, 0.5 mM 
EDTA, 0.5 mM DTT or 50 mM Tris-Cl pH 7.5, 300 mM NaCl, 0.5 mM EDTA, 0.5 mM 
TCEP. Data were collected on a Jasco model 815 spectrometer using a 1 mm cuvette at 
25ºC. Multiple wavelength scans (typically 8) were collected between 260 and 195 or 
197 nm at 1 nm intervals. Recorded CD spectra in millidegrees were averaged, corrected 
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for buffer, and then converted into mean residue ellipticity in deg cm2 dmol#1 using the 
formula,  
[!] = !obs / (c · l · n) 
in which !obs is observed ellipticity in millidegrees, c is the molar protein concentration, l 
is the path length of the cuvette in millimeters, and n corresponds to the number of amino 
acid residues. CD data were analyzed using the K2d algorithm 
(http://www.embl.de/~andrade/k2d/) (20).  
Intact protein mass spectrometry. Intact proteins were reduced, alkylated using 
iodoacetamide, and then dialyzed against 50 mM ammonium bicarbonate. Ten µg of each 
protein was dried separately using a lyophilizer. Protein was resuspended in 5 µl of 50% 
acetonitrile (ACN), 2.5% formic acid (FA) and then an additional 15 µl of 2.5% ACN, 
2.5% FA for a final concentration of 14.4% ACN, 2.5% FA. Five µl was loaded, using a 
MicroAS autosampler and Surveryor Pump Plus HPLC (Thermo Electron), on to a nano-
ESI microcapillary column with an internal diameter of 100 µm and packed with 12 cm 
of reverse-phase C4 resin. HPLC solvent A was 2.5% ACN, 0.15% FA. HPLC solvent B 
was 99.85% ACN, 0.15% FA. After a 15 min isocratic loading in solvent A, proteins 
were eluted into a LTQ-orbitrap (Thermo Electron) hybrid mass spectrometer using a 
20%-80% ACN gradient. Mass measurements were made in the orbitrap at 30,000 
resolution.  
DNA-binding assays. An enzyme-linked immunosorbent assay (ELISA) was 
conducted using synthetic biotinylated ssDNA probes (Table S1) immobilized on 
StreptaWells (Roche Applied Science) at a concentration of 0.5 nM as previously 
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described (13). Briefly, ssDNA-coated wells were incubated overnight with 1.0 nM 
solutions of full-length NHis-Pur" or the core fragment in binding buffer consisting of 20 
mM Hepes pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT, 1.0 µg/ml dT32 with 
0.2% w/v BSA and 0.05% v/v Tween& 20. Nucleoprotein complexes were detected by 
sequentially washing and then incubating the wells with 1) 1.0 µg/ml primary rabbit 
polyclonal antibody recognizing the Pur! 210-229 epitope (4), 2) 1:8000 dilution of 
secondary horseradish peroxidase-coupled goat anti-rabbit antibody (Santa Cruz 
Biotechnology, Inc.), and 3) ABTS chromogenic substrate solution (Millipore).  
A competitive colorimetric DNA-binding assay was performed using microtiter wells 
coated with 20 nM NHis-Pur! plus 5.0 µg/ml BSA carrier as previously described (13]. 
Briefly, Pur!-coated wells were incubated with 0.5 nM biotinylated PE32-F ssDNA in 
the presence of selected concentrations of fluid-phase competitor (either full-length 
NHis-Pur! or the core fragment) diluted in binding buffer. After overnight incubation at 
25ºC, wells were sequentially washed and incubated with solutions containing 
ExtrAvidin&-peroxidase diluted 1:2000 followed by ABTS chromogenic substrate 
(Millipore). In both the direct ELISA and competitive DNA-binding approaches, the 
peroxidase substrate reaction was quenched by the addition of an equal volume of 1% 




Identification of a trypsin-resistant core domain in recombinant Pur! . To assess 
the extent of protein asymmetry and existence of tertiary folding within Pur!, purified 
recombinant NHis-Pur! was subjected to limited trypsin digestion at a concentration in 
which the protein would be predicted to be mostly dimeric (18). The proteolytic products 
were then resolved by SDS-PAGE under reducing conditions and visualized by staining 
with Coomassie Blue (Fig. 2-1A). At early time points, four prominent bands were 
observed that included full-length NHis-Pur! and three closely spaced products of trypsin 
digestion. Prolonged incubation with trypsin up to 2 hours reduced the number of 
resolved bands to a single major fragment of Mr ~32 kDa (~30 kDa when taking into 
account the well documented anomalous electrophoretic mobility of Pur! (4,18)). 
Importantly, a fragment of identical size was also generated in more dilute solutions of 
Pur! suggesting that a protease-resistant domain is intrinsic to the monomeric form of the 
protein as well (Fig. 2-1C).  
Primary structure of the Pur!  core tryptic fragment. Tryptic digests of Pur! at 
various time points were probed by western blotting with antibodies specific for the N-
terminal 6%His tag or Pur! peptide sequences spanning amino acids 302-324 or two 
internal regions from 42-69 and 210-229 (Fig. 2-1B). Epitope mapping revealed that the 
core fragment present at the 90 min and 2 h time points nominally contained Pur! 
sequences from residues 42-69 and 220-229 but was missing the 6%His N-terminus and 
some C-terminal residues. Southwestern blotting confirmed that the core tryptic fragment 
retains the ability to bind ssDNA (Fig. 2-1D). Because tryptic cleavage at R10 and R28 
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would theoretically produce peptides with N-terminal polyglycine stretches of 9 and 8 
residues, we elected to perform targeted LC-MS/MS analysis (as opposed to Edman 
sequencing) of the core ~30 kDa fragment in comparison to the full-length protein after 
further in-gel tryptic digestion in order to map the N- and C-terminal boundary peptides 
of the core fragment. As predicted, a prominent tryptic fragment corresponding to 
GGGGGGGGPGGEQETQELASK was identified consistent with the N-terminus 
beginning at G29 (Fig. S2-1A and Table S2-2). Other identified peptides indicated that 
the likely C-terminus of the core fragment extends just beyond the psycho motif to 
residue 305 (Fig. S1B and Table S2-2). To validate this conclusion, we also analyzed 
full-length NHis-Pur! and the core fragment via intact protein ESI-LC-MS and found 
that the molecular mass of the core fragment does indeed correspond to residues 29-
305/306 (Fig. 2-2).  
Quaternary structure and folding of the Pur!  core tryptic fragment. The purified 
core fragment was subjected to calibrated SEC to determine whether the protein exists as 
a monomer or dimer at concentrations in the micromolar range. As is evident from the 
elution profile, the Pur! core fragment overlaps with BSA (~66 kDa), which is consistent 
with a dimer (Fig. 2-3A). The relative broadness of the peak, however, is suggestive of a 
reversible monomer-dimer equilibrium just as previously documented for the full-length 
protein (18). Comparative analysis of full-length NHis-Pur! and the core fragment by CD 
spectrometry indicated that the core fragment is stably folded (Fig. 2-3B). The modest 
increase in negative ellipticity between 210 and 222 nm seen with the Pur! core implies a 




Figure 2- 1. Identification of a core trypsin-resistant domain in Pur!. (A) Recombinant 
NHis-Pur! at 3.0 µM was combined with trypsin at 10:1 mass ratio. Aliquots were 
removed at the indicated time points. Proteolytic fragments were separated by 12% SDS-
PAGE under reducing conditions and visualized by staining with Coomassie& Brilliant 
Blue. (B) Tryptic digestion mixtures were separated by 10% SDS-PAGE and protein 
fragments were either stained with Coomassie& Brilliant Blue (Coo Blue) or transferred 
to a PVDF membrane for immunoblotting with antibodies recognizing the NHis tag or 
Pur! epitopes B42-69, B210-229, or B302-324. (C) NHis-Pur! at 9.0 nM was incubated 
with trypsin at a 1:10 mass ratio. Aliquots were removed at the indicated time points and 
subjected to reducing SDS-PAGE and western blotting using a primary antibody 
recognizing the 210-229 epitope. (D) A tryptic digest of NHis-Pur! was subjected to 
southwestern blotting with a SM"A-derived probe. The arrow in panels A, C, and D 
identifies the core ~30 kDa fragment liberated by trypsin digestion.  
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random coil-forming N- and C-terminal sequences. Although this feature was observed in 
both low and high salt buffers, the high glycine content of full-length NHis-Pur! (22%) 
precluded the computational acquisition of statistically valid numerical values of 
secondary structure (21). 
DNA-binding properties of the Pur!  core trypsin-resistant fragment. Since 
qualitative southwestern blotting demonstrated the capacity of the core fragment to 
interact with ssDNA (Fig. 2-1D), we next studied the ssDNA-binding affinity and 
specificity of the isolated Pur! core domain in comparison to the full-length protein. A 
colorimetric, microtiter well-based competition assay was first employed to establish the 
relative affinity of the core fragment for the SM"A-derived PE32-F element in solution. 
As shown in Fig 4A, the competition curve for the core fragment is shifted to the left 
relative to the full-length protein implying a slightly higher binding affinity for the 
biotinylated PE32-F probe. In support of this contention, the calculated IC50 values for 
the full-length protein and the core fragment were 1.3 and 0.5 nM, respectively. These 
values are consistent with previous estimates of the macroscopic binding affinity of Pur! 
for this sequence element based on quantitative band-shift and footprinting assays (17).  
An ELISA-based assay was used to assess the DNA-binding specificity of the core 
fragment in comparison to the full-length protein using SM"A-derived cis-element 
probes in both single-stranded and double-stranded configuration (12,13). These assays 
were conducted with limiting amounts of purified protein (1.0 nM) and biotinylated DNA 




Figure 2- 2. Intact protein nano-ESI LC-MS spectra of NHis-Pur" and the core tryptic 
fragment. A basic deconvolution of the acquired spectra for full-length NHis-Pur! (A) 
and the core fragment (B) was performed using ProMass (version 25.0.1) using an input 
m/z range of 500-1,550 and an output m/z range of 20,000-40,000. The insets show the 
deconvoluted masses for the proteins based on the composite isotopic envelopes. The 
spectra are labeled to denote the measured and theoretical (boxed) m/z values for a range 
of charge states. Note for the Pur" core fragment, tryptic digestion could lead to a ragged 
carboxyl-terminus with or without the protein containing Arg306. This is reflected in the 
overlapping isotopic envelopes and deconvoluted masses exhibiting mass differences of 
approximately the mass of arginine (156.1 daltons). The observed and calculated masses 
for full-length and core Pur" with their respective methionines variably oxidized are 
indicated above their respective spectra. 
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Figure 2- 3. Structural analysis of the Pur" core tryptic fragment via SEC and CD 
spectrometry.  (A) A 1.5 x 98-cm column packed with Sephacryl S200 HR resin was 
calibrated with six different molecular weight standards (!). Resolved peaks 
corresponding to BSA (66 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa), and 
cytochrome c (12.4 kDa) are highlighted. In a separate run, the elution of purified Pur" 
core fragment (0.5 mg loaded) was monitored at 280 nm ("). Inset, SDS-PAGE analysis 
of purified Pur! proteins. (B) CD scans of full-length NHis-Pur! and the core tryptic 
fragment were obtained in high salt buffer. The spectrum of the core fragment is 
consistent with loss of putative N- and C-terminal random coil-forming sequences.     
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Fig. 4B, the isolated core domain preferentially interacts with purine-rich sense (forward) 
strands of the PE32 and SPUR32 elements. With respect to the PE32 sequence, 
individual or combined mutation of the high affinity 3´ and 5´ binding sites and low 
affinity internal site (17), reduced the interaction of full-length NHis-Pur! and the core 
tryptic fragment in an analogous fashion (Fig. 2-4C). To ascertain whether the presence 
of DNA would affect the susceptibility of the full-length protein to proteolysis, limited 
tryptic digestion was carried out with solutions containing either polydeoxythymidylate 
(dT32) as a nonspecific control or PE32-F. As shown in Fig. 2-4D, although the core 
fragment was generated in both instances, the presence of equimolar amounts of PE32-F 
protected the core from complete digestion. These results reinforce the conclusion that 




Figure 2- 4. Assessment of the ssDNA-binding affinity and specificity of the Pur! core 
tryptic fragment. (A) A competition assay was conducted with 0.5 nM PE32-bF in the 
presence of a fixed amount of solid-phase NHis-Pur! and varying amounts of fluid-phase 
NHis-Pur! (!) or the core fragment  ("). Data points were fit to a four parameter 
logistic curve using SigmaPlot 9.0 (Systat Software, Inc.). (B, C) ELISAs were 
performed to compare the binding of NHis-Pur! and the core fragment to StreptaWell-
immobilized DNA probes corresponding to wild-type (B) or mutated (C) SM"A cis-
elements and a telomeric repeat, (TTAGGG)4. (D) Limited tryptic digestion of NHis-
Pur! at 5.0 µM was carried out in the presence of equimolar dT32 (lanes 2-8) or PE32-F 
(lanes 9-15). Lane 1 contains SigmaMarker' proteins. Arrow shows the core fragment.  
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DISCUSSION 
In an earlier study, we speculated that Pur! may possess some degree of intrinsic 
structural asymmetry based on hydrodynamic analyses indicating that the Pur! dimer is 
elongated (18). Limited proteolysis coupled with the biochemical characterization of 
peptide fragments resistant to digestion is a classic approach used to identify dimerization 
regions and/or potential sources of structural asymmetry in DNA-binding proteins 
(22,23). Taking into account the modular arrangement of predicted secondary structural 
elements in Pur! (Fig. S2-2) and the necessity of all corresponding class I and class II 
repeats for ssDNA-binding function (11), we hypothesized that these elements might fold 
in such a way as to protect the central domain of the protein from digestion by trypsin 
while leaving the putatively more flexible N- and C-termini exposed. Results of our 
limited proteolysis experiments validated this prediction by identifying a trypsin-
resistant, core ssDNA-binding domain extending from residues 29-305. Interestingly, this 
domain contains the minimal ssDNA/RNA-binding region (residues 37-263) mapped by 
deletion mutagenesis (11) plus the so-called psycho motif, which is predicted to be "-
helical (Fig. S2-2). Functionally, the Pur! core tryptic fragment mirrors the full-length 
protein in terms of ssDNA-binding specificity but shows a modestly higher binding 
affinity presumably due to the absence of an acidic C-terminal tail (Fig. S2-2). This 
finding differs from previous results obtained with the 37-263 mutant, which exhibited 
much weaker ssDNA-binding affinity (11). Hence, these new data point to a critical role 
for residues 264-305 in facilitating high affinity binding of Pur! to ssDNA.  
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These findings are particularly intriguing when considered in conjunction with results 
of small angle-x-ray scattering measurements and SEC analysis of a Dm Pur" construct 
containing PUR repeats I-III (19). Dm Pur" I-III, which is analogous to the Pur! core 
domain described herein, appears to dimerize by virtue of intermolecular interaction 
between the PUR III repeats (i.e. the third basic/aromatic repeat plus the psycho motif) 
from each monomer. As a consequence, dimeric Pur" adopts an elongated Z-like 
configuration composed of a central intermolecular PUR domain and two flanking 
intramolecular PUR domains (19). If this type of structure is also adopted by the dimeric 
form of Pur!, then the role of putative "-helix forming residues 264-305 may be to 
ensure stable self-association of the protein when tethered to ssDNA. Importantly, this 
type of structural arrangement fits nicely with the cooperative multisite binding 
mechanism proposed for Pur! interaction with the PE32-F element in the SM"A gene 
promoter (17). Multisite contact via individual PUR domains is an attractive model to 
explain why Pur! interacts preferentially with cis-elements containing repeats of 
consensus and non-consensus PUR elements such as those present in the promoter 
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In-gel digestion, mass spectrometry (MS), and data analysis. Cubed gel bands of 
full-length NHis-Pur! or the Pur! core fragment were rinsed with water, destained with 
50% acetonitrile (ACN)/50% ammonium bicarbonate, dehydrated with 100% ACN, and 
subjected to in-gel digestion with 6 ng/µl sequencing grade modified trypsin (Promega) 
in 50 mM ammonium bicarbonate for 2 h at 37ºC. Peptides were extracted once with 
50% ACN, 2.5% formic acid (FA); and once with 100% ACN. Dried peptides were 
resuspended in 2.5% ACN, 2.5% FA and loaded using a Micro AS autosampler (Thermo 
Electron) and a Surveyor MS Pump Plus (Thermo Electron) onto a nano-electrospray 
microcapillary column packed with 15 cm of reverse phase MagicC18 material (5 #m, 
200Å, Michrom Bioresources, Inc.). Elution was performed with a 5-35% ACN (0.15 % 
FA) gradient over 41 min, after a 14 min isocratic loading at 2.5% ACN, 0.15% FA. 
Solvent A was 2.5% ACN, 0.15% FA and Solvent B was 99.85% ACN, 0.15% FA. Mass 
spectra were acquired in a LTQ-XL linear ion trap mass spectrometer (Thermo Electron). 
Throughout the entire run a sequence of nine scan events was repeated: 1. Precursor 
survey (MS1) scan (390-1600 m/z). 2. Data-dependent MS/MS scan performed on the 
most intense ion from the survey scan. 3-9. Targeted MS/MS scans on the following m/z 
(+/- 1.5) values (note that the corresponding peptide and charge state are indicated for 
each targeted m/z value which is the peptide average mass/z of the indicated peptide): 
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610.96 (GGGGGGGGPGGEQETQELASK, 3+), 856.94 (YADEM*KEIQERQR, 2+); 
571.63 (YADEM*KEIQERQR, 3+); 714.79 (YADEM*KEIQER, 2+); 476.86 
(YADEM*KEIQER, 3+); 720.76 (GGGGGGGGGPGGFQPAPR, 2+); 480.84 
(GGGGGGGGGPGGFQPAPR, 3+). M* indicates an oxidized methionine. These 
targeted values were chosen as they correspond to the predicted tryptic peptides at the 
termini of full-length Pur! or the core fragment. Mass spectral data were searched against 
a full-length mouse Pur! protein database using Turbo SEQUEST (Thermo Electron, 
Version 27, Revision 12) requiring no enzyme specificity, and a 2 Da precursor mass 
tolerance. Differential modification of 16.0 Da on methionine residues was permitted. 
Southwestern blotting. Proteolytic fragments generated during limited trypsin 
digestion were separated by SDS-PAGE on a 10% mini-gel and then electroblotted onto 
PVDF membrane. The membrane was blocked in 2% w/v bovine serum albumin (BSA) 
dissolved in 25 mM Tris-Cl pH 7.5, 150 mM NaCl, and 0.05% v/v Tween& 20 (TBST) 
for 16 h at 4oC. Blocking buffer was removed and the membrane was then gently mixed 
at room temperature with a 5 ml solution of 10 nM ssDNA probe (PE32-bF, Table S1) 
diluted in 0.2% w/v BSA/TBST with 2.0 µg/ml poly[dI-dC] (Roche Applied Science). 
After incubating for 2 h, the membrane was washed four times with TBST and a 5 ml 
solution of ExtrAvidin&-peroxidase (Sigma-Aldrich) diluted 1:2000 in BSA-TBST 
buffer was applied for 1 h. The membrane was washed as above followed by application 
of ECL' western blot substrate as directed by the manufacturer (Pierce). The membrane 
was covered in plastic wrap and exposed to RXB-blue sensitive x-ray film (IBF-Medix).  
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Secondary structure prediction. Software tools available at the Expert Protein 
Analysis System (ExPASy) proteomic server of the Swiss Institute of Bioinformatics 
were used to predict the presence and arrangement of secondary structural motifs in 
mouse Pur! based on primary sequence. The programs and software packages applied 
included Jpred, a neural network using multiple sequential network layers [1], SSpro, 
one-dimensional recurrent neural network [2], GenTHREADER, a sequence profile 
based fold recognition program [3], PROFsec, a profile based neural network [4], Porter, 
a bidirectional recurrent neural network with two independent training models [5], and 
APSSP2, a neural network and nearest neighbor approach [6]. 
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SUPPLEMENTARY TABLES AND FIGURES 
 
Table S3- 1. Sequences of 3´-biotinylated oligonucleotides used in this study 
__________________________________________________________________ 
 
Designation     Sequence (5´(3´) 
__________________________________________________________________ 
SPUR32-bFa   GAAGCGAGTGGGAGGGGATCAGAGCAAGGGGC  
SPUR32-bR   GCCCCTTGCTCTGATCCCCTCCCACTCGCTTC 
PE32-bFb   GGGAGCAGAACAGAGGAATGCAGTGGAAGAGA  
PE32-bR   TCTCTTCCACTGCATTCCTCTGTTCTGCTCCC  
PE32-bF-5T7   TTTTTTTGAACAGAGGAATGCAGTGGAAGAGA  
PE32-bF-IT7   GGGAGCAGAACAGTTTTTTTCAGTGGAAGAGA  
PE32-bF-3T7   GGGAGCAGAACAGAGGAATGCAGTTTTTTTTA  
PE32-bF-35T7  TTTTTTTGAACAGAGGAATGCAGTTTTTTTTA  
PE32-bF-3I5T7  TTTTTTTGAACAGTTTTTTTCAGTTTTTTTTA  
PE32-bF-5IT7  TTTTTTTGAACAGTTTTTTTCAGTGGAAGAGA  
PE32-bF-3IT7  GGGAGCAGAACAGTTTTTTTCAGTTTTTTTTA 
(TTAGGG)4   TTAGGGTTAGGGTTAGGGTTAGGG  
__________________________________________________________________ 
aCorresponds to nucleotides #59 to #28 of the mouse SM"A gene. 











Table S3- 2. Boundary peptides identified by targeted LC-MS/MS scans of in-gel 
digested full-length NHis-Pur! in comparison to the core 30 kDa fragment 
_____________________________________________________________ 
  
Sequence (N ( C)   Location  NHis-Pur! Core fragment 
________________________________________________________________________ 
GGGGGGGGGPGGFQPAPR N-terminal  +  # 
GGGGGGGGPGGEQETQELASK N-terminal  +  + 
YADEMKEIQER   C-terminal  +  + 
DKLYER    C-terminal  +  + 
RGGGSGGGDESEGEEVDED C-terminal  +  # 
GGGSGGGDESEGEEVDED C-terminal  +  # 
________________________________________________________________________
_ 
+, Peptide detected. 





Figure S2- 1. LC-MS/MS analysis of full-length Pur! and the core fragment after in-gel 
tryptic digestion. Low energy collision-induced dissociation (CID) MS/MS spectra are 
shown for the putative N-terminal (A) and C-terminal (B) boundary peptides of the core 
~30 kDa fragment. Asterisks in (A) indicate ions that are explained by water losses off of 
b- and y-type ions. Daggers in (A) indicate additional singly- or doubly-charged y- or b-
type ions. For the N-terminal peptide (A) note the high relative abundance of the y13 ion, 
characteristic in this instrumentation of low energy CID fragmentation N-terminal to 
proline residues. The N-terminal peptide was found in both doubly-charged (shown) and 
triply-charged (not shown) states. (C) Amino acid sequence of full-length NHis-Pur! 
showing the location of boundary peptides identified by LC-MS/MS analysis (red) of the 




Figure S2- 2. Predicted arrangement of secondary structural elements in Pur!. The 
diagram presents a hypothetical map generated by six different secondary structure 
prediction algorithms in which arrows stand for "-helices, and open rectangles represent 
!-strands. The primary sequence of the protein is shown with basic/aromatic class I 
motifs highlighted in blue, acidic/leucine-rich class II motifs in red, psycho motif in 
purple, and glycine-rich regions in green. Arrowheads denote the positions of R57 and 
R96 in the first class I and class II repeat modules, respectively. In the postulated model, 
all three basic/aromatic repeats are composed of three or four !-sheets. In contrast, the 
acidic/leucine-rich regions are predicted to be mostly "-helical, except for a disordered 
polyglycine stretch in the second class II repeat. The psycho motif is also presumed to be 
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predominantly "-helical. The N- and C-terminal regions are predicted to form random 
coils. Overall, the proposed model concurs with results of limited tryptic digestion 
indicating that Pur! possesses an organized core nucleic-acid binding domain and more 
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ABSTRACT 
A hallmark of dysfunctional fibroblast to myofibroblast differentiation associated 
with fibrotic disorders is persistent expression of ACTA2, the gene encoding the cyto-
contractile protein smooth muscle "-actin. In this study, a PURB-specific gene 
knockdown approach was used in conjunction with biochemical analyses of protein 
subdomain structure and function to reveal the mechanism by which purine-rich element 
binding protein B (Pur!) restricts ACTA2 expression in mouse embryo fibroblasts 
(MEFs). Consistent with the hypothesized role of Pur! as a suppressor of myofibroblast 
differentiation, stable short hairpin RNA-mediated knockdown of Pur! in cultured MEFs 
promoted changes in cell morphology, actin isoform expression, and cell migration 
indicative of conversion to a myofibroblast-like phenotype. Promoter-reporter assays in 
transfected Pur! knockdown MEFs confirmed that these changes were attributable, in 
part, to de-repression of ACTA2 transcription. To map the domains in Pur! responsible 
for ACTA2 repression, several recombinant truncation mutants were generated and 
analyzed based on hypothetical, computationally-derived models of the tertiary and 
quaternary structure of Pur!. Discrete subdomains mediating sequence- and strand-
specific cis-element binding, protein-protein interaction, and inhibition of a composite 
ACTA2 enhancer were identified using a combination of biochemical, biophysical, and 
cell-based assays. Our results indicate that the Pur! homodimer possesses three separate 
but unequal single-stranded DNA-binding modules formed by subdomain-specific inter- 
and intramolecular interactions. This structural arrangement suggests that the cooperative 
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assembly of the dimeric Pur! repressor on the sense strand of the ACTA2 enhancer is 
dictated by the association of each subdomain with distinct purine-rich binding sites 
within the enhancer.  
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INTRODUCTION 
The myofibroblast is a unique cell type that exhibits an ensemble of phenotypic 
properties typical of a collagenous matrix-producing fibroblast and a contractile smooth 
muscle cell (1). In the body, pre-formed myofibroblasts play an important structural role 
in certain developing and adult tissues and organs (1, 2). On the other hand, emergent 
myofibroblasts are critical to the formation and remodeling of granulation tissue during 
wound healing as they provide the contractile machinery and mechanical strength 
necessary for wound closure (3-5). While transient differentiation of resident connective 
tissue fibroblasts to myofibroblasts is a normal physiological response to tissue injury, 
persistent myofibroblast activation is associated with hypertrophic scarring, pathologic 
organ fibrosis, aberrant vascular remodeling, and dysfunctional stromal responses to 
neoplasia (6-9). Consequently, an improved understanding of the molecular mechanisms 
underlying myofibroblast trans-differentiation may reveal novel drug targets to limit 
scarring, fibrosis, and tumor progression.  
Among the markers of myofibroblast conversion, expression of ACTA2, the gene 
encoding smooth muscle "-actin (SM"A)3 is recognized as one of the key determinants 
of the transition to a contractile phenotype (10-12). Based largely on comparing ACTA2 
reporter gene activity in myogenic versus non-myogenic cell lines, early reports 
suggested that activation of ACTA2 transcription in fibroblasts is mediated by serum-
derived, growth factor-dependent signaling leading to induction of an otherwise repressed 
5) enhancer-promoter (13-15). Later studies revealed that the 5) flanking region of 
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ACTA2 contains a variety of discrete but functionally-interacting cis-elements that serve 
as binding sites for certain muscle-associated, growth factor-inducible, or basal trans-
activators found in ACTA2-expressing fibroblasts (16-19). In particular, combinatorial 
interactions between a transcription enhancer factor 1 (TEF1)-binding muscle CAT 
(MCAT) motif, two serum response factor (SRF)-interacting CArG boxes, and several 
specificity protein 1 and 3 (Sp1/3)-binding GC-rich elements are necessary to drive high 
level ACTA2 transcription in differentiating myofibroblasts (17, 20). Conversely, in 
undifferentiated fibroblasts, the activity of a composite MCAT/CArG/GC box enhancer 
is apparently suppressed by several single-stranded DNA (ssDNA)-binding repressors 
that interact with the opposing strands of an asymmetric polypurine/polypyrimidine-rich 
(Pur/Pyr) tract containing the core MCAT motif (15, 21). Cell-based promoter 
mutagenesis studies in conjunction with nucleoprotein interaction analyses with double-
stranded and single-stranded probes led to the identification of purine-rich element 
binding proteins A and B (Pur" and Pur!) and Y-box binding protein 1 (YB-1) as the key 
factors in strand-specific Pur/Pyr tract recognition and repression of the composite 
ACTA2 enhancer (17, 22).  
Pur" and Pur! are members of a small family of nucleic acid-binding proteins that 
interact with purine-rich ssDNA or RNA sequences homologous to the so-called PUR 
element originally described in eukaryotic gene flanking regions and origins of DNA 
replication (23-25). Despite the fact that Pur" and Pur! share ~70% sequence identity 
and exhibit similar ssDNA-binding and helix-destabilizing properties in vitro (26-28), 
comparative gain-of-function and loss-of-function analyses conducted in transiently-
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transfected fibroblasts and vascular smooth muscle cells point to Pur! as the dominant 
repressor of ACTA2 in these cell types (29, 30). In keeping with its general biological role 
as a potent repressor of genes that encode contractile proteins, Pur! has also been 
reported to negatively-regulate MYH6 and MYH7 in cardiac and skeletal myocytes (31-
33). More recent studies suggest that Pur! repressor expression in muscle cells is tightly 
controlled at the post-transcriptional level by certain muscle-restricted microRNAs to 
ensure appropriate myofiber composition for sustained cardiac and skeletal muscle 
performance in response to stress (34, 35).  
Apart from hydrodynamic analyses revealing that Pur! can reversibly self-associate 
to form an elongated homodimer in the absence of ssDNA (36), comparatively little is 
known about the higher order structural domains in either the Pur! monomer or dimer 
that confer specific and high-affinity interaction with purine-rich elements in ACTA2 or 
any other target gene. A previous report demonstrated that Pur! interacts in a sequential 
and cooperative manner with the sense strand of the MCAT-containing Pur/Pyr element 
from mouse ACTA2 to form a high affinity 2:1 Pur!:ssDNA complex (37). While the 
primary structure of Pur! is similar to Pur" in terms of the presence of three distinct 
regions of internal homology (dubbed PUR repeats I, II, and III) (38), Pur! contains 
several unique intervening sequences with high glycine and proline content that may 
affect the structural and functional properties of the protein (26). Importantly, the x-ray 
crystal structure of a truncated version of Drosophila melanogaster (56) Pur" (amino 
acids 40-185) revealed a monomeric Whirly fold-like DNA-binding domain formed by 
the intramolecular interaction of the first two PUR repeat sequences (39). On the other 
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hand, we recently identified a core tryptic fragment of Pur! (amino acids 29-305) that 
contains all three PUR repeats, self-associates in the absence of nucleic acid, and retains 
the ability to interact with the purine-rich strand of the ACTA2-derived MCAT element 
with high-affinity and specificity (40). In this study, the putative biological role of Pur! 
in suppressing ACTA2 expression and restricting myofibroblast cyto-differentiation was 
first validated via a stable gene knockdown approach. In silico modeling of protein 
structure coupled with empirical analyses of protein function were then used to delineate 
the relevant domains in Pur! that mediate ACTA2-specific nucleoprotein interaction and 
repression of the composite MCAT/CArG/GC box enhancer.  
 
MATERIALS AND METHODS 
Cell culture and extraction. AKR-2B MEF cell lines stably-transduced with 
lentiviral vectors encoding a PURB transcript-specific short hairpin RNA (shRNA) or a 
scrambled control RNA were generated as described in (30). Subcloned cell lines were 
propagated in McCoys 5A medium (Gibco'/Invitrogen) containing 5% heat-inactivated 
fetal bovine serum (FBS) and 10 µg/ml blasticidin in a humidified 5% CO2 incubator and 
studied at passage number 5 to 15. Phase contrast images of live cells were obtained on a 
Zeiss Axiovert model 200 inverted microscope equipped with an AxioCam MRm digital 
camera. Assays used to compare the growth and migratory properties of derived cell lines 
are detailed in Supporting Information. In timed growth factor-treatment experiments, 
cells were seeded at a fixed density and then switched to serum-free MCDB-402 medium 
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(JRH Biosciences) for 36 to 48 h. Cells were then treated for 24 h with either 10% FBS 
or 2.5 ng/ml recombinant human transforming growth factor !1 (TGF-!1) (R & D 
Systems) diluted in MCDB-402 medium. Confluent monolayers of growth factor-
stimulated cells were washed three times with ice-cold phosphate buffered saline (PBS) 
and then extracted with 1% Reporter Gene Assay Lysis Buffer (Roche Applied Science) 
supplemented with protease inhibitors 0.5 mM phenylmethanesulfonyl fluoride and 1 
µg/ml each of pepstatin A, leupeptin, and aprotinin. Soluble lysates and cell remnants 
were collected by centrifugation at 15,800 % g for 10 min at 4°C. Total protein content in 
cleared lysates was measured by BCA' Protein Assay (Thermo Scientific) using bovine 
serum albumin (BSA) as a standard. Insoluble pellets were further extracted with a 
denaturing solvent consisting of 8 M urea, 100 mM sodium phosphate, 10 mM Tris-Cl 
pH 8.0 plus protease inhibitors. Denatured lysates were cleared by centrifugation and 
assayed for protein content as described above.  
Promoter:reporter constructs. Murine ACTA2 promoter-chloramphenicol 
acetyltransferase reporter constructs (pVSMP8-CAT and pVSMP4-CAT) have been 
described elsewhere (14, 30, 41). The corresponding ACTA2 promoter-luciferase 
reporters were constructed as follows. A ~3.6 kb fragment was released from pVSMP8-
CAT by sequential treatment with SphI, mung bean nuclease, and BamHI. A ~240 bp 
insert was released from pVSMP4-CAT by sequential treatment with SalI, mung bean 
nuclease, and BamHI. Restriction fragments were ligated into SmaI/BglII-digested and 
alkaline phosphatase-treated pGL3-Basic vector (Promega) to generate pVSMP8-Luc and 
pVSMP4-Luc. Following transformation into E. coli HB101 cells, ampicillin-resistant 
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clones were selected for propagation and plasmid purification (Roche Applied Science). 
The fidelity of plasmid constructs was confirmed by restriction enzyme digestion 
followed by automated DNA sequencing performed by the Vermont Cancer Center DNA 
Analysis Facility.  
Expression vectors. Bacterial and mammalian expression vectors encoding full-
length, N-terminal hexahistidine-tagged mouse Pur! (pQE30-NHis-Pur! and pCI-NHis-
Pur!) were described in previous reports (17, 22). Expression plasmids encoding NHis-
Pur! truncation proteins corresponding to amino acids 41-112 (Pur! I), 125-210 (Pur! 
II), 209-303 (Pur! III), 41-210 (Pur! I-II), 125-303 (Pur! II-III), and 41-303 (Pur! I-II-
III) were constructed following a similar strategy outlined in (29) and as further detailed 
in Supporting Information.  
Monoclonal antibodies. With the exception of antibody screening assays, all other 
procedures involved in generating murine and rat monoclonal antibodies (mAbs) 
recognizing Pur" and/or Pur! were carried out by a commercial vendor (Green Mountain 
Antibodies). These included rodent immunization, fusion of mouse or rat splenocytes 
with NS-1 myeloma cells, subcloning of hybridoma cells (2 rounds), and in vitro 
production, purification, and isotype/subclass determination of derived mAbs. The 
specific antigens used for immunization were keyhole limpet hemocyanin-coupled 
peptides corresponding to amino acid sequences B42-69, B302-324, and A291-313 of 
mouse Pur! and Pur", respectively (22). Animals were immunized with each individual 
peptide or a combination of all three peptides. The relative affinity and specificity of 
purified mAbs were evaluated by direct enzyme-linked immunosorbent assay (ELISA) 
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using immobilized peptides or full-length NHis-Pur" or NHis-Pur! as described in 
Supporting Information and shown in Figure S1.  
Computational modeling of protein structure. A homology model of Mus 
musculus (Mm) Pur! was generated based on the structure of Drosophila melanogaster 
(56) Pur" repeats I-II (amino acids 40-185) using web-based modeling servers and a 
bioinformatics approach described previously (38, 39). A pair-wise multiple sequence 
alignment of Mm Pur! and Dm Pur" indicating 52% sequence identity was obtained 
using ClustalW (42, 43). The sequence alignment was submitted to the HHrepID and 
PSIPRED web servers (44, 45) under default parameters to identify repeated sequences 
and predict secondary structural elements within Pur! (26). To generate a model 
consistent with these results, the FASTA sequence of Mm Pur! was submitted to the I-
TASSER web server (46, 47) to generate a homology model of Pur! repeats I-II using 
Dm Pur" I-II (3K44) as a template (39). On the basis of the internal sequence homology 
of the three Pur! repeats, Pur! III was independently predicted by SWISS-MODEL (48-
50) by threading the sequence of the third Pur! repeat onto the structure of Dm Pur" I-II. 
Predicted intermolecular interaction between two Pur! III repeats was modeled by 
rotating the Mm Pur! III repeats of two monomers into an extended conformation and 
aligning them on Dm Pur" I-II using Coot (51). Energy minimization of the Pur! 
homodimeric homology model was completed using CNS version 1.2 (52, 53) to relax 
close contacts and to regularize local bond and angle geometry. Computationally-derived 
structures were viewed and depicted using PyMOL (54).  
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Recombinant protein purification. Full-length NHis-Pur! and selected truncation 
proteins were expressed in and isolated from E. coli JM109 cells using chromatographic 
methods optimized for each particular recombinant protein as detailed in Supporting 
Information. NHis-Pur!-enriched fractions obtained by metal chelate affinity, heparin 
affinity, or size exclusion chromatography (SEC) were monitored for purity by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing 
conditions and staining with Coomassie& Brilliant Blue R-250. Wide range 
SigmaMarker' proteins (Sigma-Aldrich) were used as molecular weight standards. The 
protein concentration of pooled fractions was determined by absorbance measurement 
using theoretical molar extinction coefficients at 280 nm of 20,400 M#1 cm#1 for full-
length NHis-Pur! and NHis-Pur! I-II-III, 7,450 M#1 cm#1 for NHis-Pur! I-II, and 12,950 
M#1 cm#1 for NHis-Pur! III (55). Protein preparations were routinely screened to ensure 
the absence of contaminating nucleic acid as previously described (36). Protein 
preparations were also monitored for the presence of nuclease activity by incubating 1.0 
µM protein stocks with 2 µg of either pBLCAT3 plasmid or M13mp18 ssDNA (Bayou 
Biolabs) for 1 h at 37°C. The integrity of the DNA substrates was then evaluated by 
agarose gel electrophoresis. Absence of contaminating nuclease activity in recombinant 
Pur! preparations was established based on comparison to DNA substrates treated in 
parallel with 10#1 to 10#5 units of DNase I (Invitrogen).  
Calibrated SEC and circular dichroism spectroscopy. The quaternary state of 
purified truncation proteins was determined by SEC on a 1.5 % 100 cm Sephacryl& 200 
HR column calibrated with molecular weight standards blue dextran, BSA, ovalbumin, 
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carbonic anhydrase, cytochrome C, and DNP aspartate (36). The foldedness of 
recombinant proteins was assessed by CD spectroscopy. All proteins were analyzed on a 
Jasco model 815 spectrometer after dialysis into buffer consisting of 50 mM Tris-Cl pH 
7.5, 300 mM NaCl, 0.5 mM EDTA, and 0.5 mM tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP). Multiple wavelength scans were recorded at 1 nm intervals from 
195 to 280 nm on 5.0 µM protein solutions in a 1 mm cuvette at 25°C. Raw CD data were 
analyzed as previously described (40). 
Single-stranded DNA-binding assays. Direct or competitive colorimetric 
microplate-based assays were conducted with purified proteins and a 3) biotinylated 
ssDNA probe corresponding to the purine-rich strand of the murine ACTA2 5)-flanking 
sequence from #195 to #164 (PE32-bF) as previously described (40, 56). In the direct 
ssDNA-binding format, solid-phase Pur!-PE32-bF complexes were detected by ELISA 
using primary rabbit antibodies directed against amino acids 210-229 or 302-324 of 
mouse Pur! (22) or the NHis tag (His probe H-15 from Santa Cruz Biotechnology, Inc. 
or anti-6-His from Bethyl Laboratories, Inc.). In the competitive binding format, solid-
phase nucleoprotein complexes were detected with ExtrAvidin&-peroxidase (Sigma-
Aldrich). Log [protein] vs. absorbance datasets were fit to four parameter variable slope 
equations to determine EC50 or IC50 values depending on the format of the assay (Prism 
5, Version 5.04, Graphpad Software, Inc.). 
Protein-protein interaction assay. Protein-protein interaction was assessed in an 
ELISA format using microtiter wells (Costar& EIA/RIA 96 well plate, certified high 
binding, Corning Inc.) coated with 200 nM NHis-Pur! or selected truncation proteins as 
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previously described (30, 56). Nuclear extracts prepared from exponentially growing 
AKR-2B MEFs served as a source of protein binding partners of Pur! (57). The primary 
antibodies used for detection of solid-phase protein-protein complexes included rabbit 
anti-mouse Pur" 291-313 (22), rabbit anti-mouse YB-1 (MSY1) 242-269 (22), and rabbit 
anti-mouse TEF1 1-15 (17). Commercial rabbit polyclonal antibodies against SRF (G-
20), Sp1 (H-225 and PEP-2), and Sp3 (D-20) were from Santa Cruz Biotechnology, Inc. 
Transient transfection assay. AKR-2B MEFs were seeded into 6 well plates at 4.0 
%104 cells per well in McCoys 5A medium with 5% FBS. Primary mouse aortic 
outgrowth smooth muscle cells (AoSMCs) (30) were seeded at 2.5 %104 cells per well in 
DMEM with 10% FBS. After an overnight incubation at 37°C in a 5% (MEFs) or 10% 
(AoSMCs) CO2 incubator, adherent cells were transfected with 2 µg of total DNA using 
jetPEI' reagent (PolyPlus-transfection) at a ratio of 1.5 µl per µg of DNA. Transfection 
solutions typically contained 0.9 µg of pVSMP8- or pVSMP4-CAT or luciferase 
reporters, 0.1 µg of pSV40-!-Gal control reporter, and 1.0 µg of expression plasmid. 
After 48 h incubation at 37°C, cells were washed with PBS and then extracted with 1% 
Passive Lysis Buffer (Promega) supplemented with protease inhibitors. Total protein 
content was determined by BCA' or Bradford assay and individual reporters were 
measured with the use of a CAT or !-Gal ELISA kit (Roche Applied Science), 
Luciferase Assay System (Promega), or ortho-nitrophenyl-"-galactoside chromogenic 
substrate assay. Numerical datasets were subjected to one-way analysis of variance and 
Tukey’s multiple comparison test with significance set at p < 0.05 (Prism 5, Version 
5.04, Graphpad Software, Inc.). In some instances, transfected cells were processed by 
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sequential extraction using a subcellular protein fractionation kit as directed by the 
manufacturer (Thermo Scientific).  
Immunoblotting. Samples were prepared for SDS-PAGE by dilution of concentrated 
cell lysates into 6% sample preparation buffer (120 mM Tris-Cl pH 6.8, 3% w/v SDS, 
30% v/v glycerol, 0.03% w/v bromophenol blue). For less concentrated cell lysates, 
soluble protein was precipitated by adding 5 volumes of ice-cold ethanol to 1 volume of 
cell lysate and incubating for at least 1 h at #20°C. Precipitated protein was collected by 
centrifugation and dissolved in 1% SDS-PAGE loading buffer. Samples were 
supplemented with 5% v/v 2-mercaptoethanol, heated for 3-5 min at 100°C, and 
subjected to slab gel electrophoresis on 10%, 12% or 15% w/v acrylamide:bisacrylamide 
(29:1) mini-gels or 4-20% precast gradient gels (Lonza). Molecular weight standards 
were run in parallel on each gel (BenchMark' Prestained Protein Ladder, Invitrogen). 
Proteins were then electrotransferred to Immobilon&-P or Immobilon&-PSQ 
polyvinylidene difluoride membrane (Millipore) in 25 mM Trizma base, 192 mM 
glycine, 20% v/v methanol at 125 V for 90 min at 4°C. Transblots were probed with 
selected antibodies as described in (22). Primary and secondary antibodies used are listed 
in Supporting Information.  
 
RESULTS 
Derivation of Pur!  knockdown MEFs. To assess the phenotypic consequence of 
Pur! loss-of-function in a multipotent mesenchymal cell type, a lentiviral shRNA 
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expression system was used to stably-transduce AKR-2B MEFs owing to their high 
steady-state levels of Pur" and Pur! and sensitivity to inducers of myofibroblast 
differentiation (20, 22, 58). As shown in Figure 3-1A, specific knockdown of Pur! (faster 
migrating band of doublet) was confirmed in two independently-derived blasticidin-
resistant cell lines by Western blotting with the use of a newly-developed rat monoclonal 
antibody directed against a conserved PUR repeat I sequence present in both Pur" and 
Pur! (specifically, amino acids 42-69 of Pur!). Importantly, Pur" expression (slower 
migrating band of doublet) was not altered in either Pur!-only knockdown cell line (!I-
B4 and !1-G7) compared to control cells transduced with scrambled RNA (!S-E6). For 
the purpose of comparison, extract from a serendipitously-derived cell line deficient in 
Pur" expression (!I-F3) was included on the gel to highlight differences in the 
electrophoretic mobility of bands corresponding to Pur" and Pur!. To quantify relative 
differences in Pur! expression, a functional ELISA was used to measure Pur! ssDNA-
binding activity in soluble extracts of each cell line (Figure 3-1B). In keeping with the 
results of Western blotting, Pur! ssDNA-binding activity was reduced by 2.5-2.7 fold in 
the !I-B4 and !I-G7 cells in comparison to the !S-E6 control cell line. Consistent with a 
dominant Pur" loss-of-function phenotype (59), the Pur"-deficient !I-F3 cell line 
exhibited a markedly enhanced rate of cell growth relative to Pur!-only knockdown and 
scrambled control cell lines and was thus excluded from detailed study (Figure S3-2). 
Phenotypic properties of Pur!  knockdown MEFs. Analysis of growing MEF cell 
lines by light microscopy revealed that Pur!-only knockdown cells adopt a more 
elongated spindle-like morphology in comparison to control cells expressing scrambled 
 108 
RNA (Figure 3-1C). A similar but less dramatic change in morphology is evident in cells 
co-deficient in Pur". These morphological differences were readily apparent in confluent 
cell monolayers as well (Figure S3-3). To investigate the physical basis for these changes 
in cell shape, the expression of cytoskeletal actin proteins was assessed by 
immunoblotting of detergent-soluble and detergent-insoluble lysates prepared from 
serum- or TGF-!1-stimulated MEF cell lines. In serum-stimulated cells, the soluble G-
form of SM"A was the predominant actin isoform exhibiting enhanced expression in 
concert with Pur! knockdown although a slight increase in !-actin expression was 
detected as well (Figure 3-2A). Consistent with sensitization to TGF-!1-driven 
myofibroblast cyto-differentiation, a corresponding increase in both G- and F-form 
SM"A, but not !-actin, was seen in Pur! knockdown MEFs relative to the control cell 
line treated with TGF-!1 (Figure 3-2B). Pur! deficiency, however, did not promote 
acquisition of a smooth muscle cell-like protein expression pattern as other markers of 
smooth muscle differentiation including smooth muscle myosin and SM22"/transgelin 
were not detected by immunoblotting of either control or Pur! knockdown MEFs (data 
not shown). To determine whether increased expression of SM"A protein correlated with 
de-repression of ACTA2 transcription, transient transfection assays were conducted using 
a minimal MCAT- and CArG-dependent ACTA2 enhancer-promoter construct. As shown 
in Figure 3-2C, ACTA2-driven reporter expression was significantly increased in both 
Pur! knockdown cell lines in comparison to control cells implying that loss of Pur! 
repressor function is necessary and sufficient to promote ACTA2 expression and 




Figure 3- 1. Validation of constitutive Pur! knockdown in MEFs. (A) Immunoblotting of 
whole cell extracts (10 µg protein/lane) from the indicated MEF cell lines was conducted 
with a mAb (rat anti-Pur! 42-69 clone 3C3.6C1) directed against a conserved PUR repeat 
I epitope present in both Pur" (slower migrating band) and Pur! (faster migrating band). 
The Pur"/! blot was reprobed with a GAPDH mAb to confirm equivalent protein 
loading. !I-B4 and !I-G7 (lanes 1 and 3) are two distinct clonal cell lines stably 
expressing a Pur! shRNA, while !S-E6 is a control cell line stably expressing a 
scrambled RNA (lane 4). For the purpose of comparison, !I-F3 (lane 2) is a 
serendipitously isolated cell line deficient in Pur" expression. Lines and numbers on the 
left side designate the relative position and size (in kDa) of prestained protein markers. 
(B) Quantification of functional Pur! protein in extracts from the indicated MEF cell 
lines by ssDNA-binding ELISA. Bars show Pur! expression relative to !S-E6 control 
cells (mean ± SEM, n = 4). *, p < 0.05, **, p < 0.01 compared to !S-E6. (C) Phase 
contrast micrographs of subconfluent cultures of the indicated MEF cell lines viewed 




Figure 3- 2. Knockdown of Pur! enhances SM"A expression in growth factor-
stimulated MEFs. (A, B) Immunoblotting of cell extracts prepared from Pur! knockdown 
(lanes 1 and 2) and control (lane 3) MEFs stimulated with either serum (A) or TGF-!1 
(B) was conducted with mAbs against Pur"/!, SM"A, or !-actin. Pur"/! (10 µg 
protein/lane) and G-form actin (0.5 µg protein/lane) were detected in detergent-soluble 
cell lysates. F-form actins were detected in detergent-insoluble cell remnants dissolved in 
8 M urea (0.2 µg protein loaded/lane). (C) The indicated MEF cell lines were transiently 
transfected with a combination of pVSMP4-CAT and pSV-!gal promoter-reporter 
constructs. Cell extracts were prepared 48 h later and reporter enzymes were quantified 
by ELISA. Bars show the ratio of CAT to !-gal measured in each cell line normalized for 








properties of SM"A-containing myofilaments in cultured fibroblasts (60), Pur! 
knockdown MEFs also demonstrated a modest reduction in chemotactic migration toward 
serum growth factors as measured by Boyden chamber assay (Figure S3-4). 
Homology modeling of Pur!  tertiary and quaternary structure. To explore the 
physical basis for Pur!-mediated repression of ACTA2 transcription, we first set out to 
computationally model the higher order structure of Pur! based on 1) sequence homology 
with other members of the purine-rich element binding protein family, and 2) the known 
x-ray crystal structure of Dm Pur" 40-185. Primary sequence analysis of Mm Pur! using 
selected homology detection and structure prediction algorithms indicated that Pur! 
possesses the same linear arrangement of PUR repeat modules (designated I, II, III) as 
originally described in Pur" (38, 39) (Figure 3-3A). The sequences encoding Mm Pur" 
and Mm Pur! were threaded on the x-ray crystal structure of Dm Pur" residues 40-185 
(3K44) using SWISS-MODEL to assess the overall homology of the intramolecular PUR 
domain formed by PUR repeats I and II of each protein. As expected, the major 
differences were restricted to putative loop regions connecting the individual PUR I and 
II repeats while the !-strand and "-helix forming sequences were virtually 
superimposable (Figure S3-5). To create a hypothetical structure of the full-length Pur! 
monomer, PUR repeat III was independently modeled using SWISS-MODEL and the 
tertiary structure of the entire protein was constructed on the basis of an I-TASSER 
generated template (Figure 3-3B). Like PUR repeats I and II, PUR repeat III is predicted 
to possess similar !!!!" topology. However, a putative random coil-forming region 
located between PUR repeats II and III may impart some degree of flexibility as to the 
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position of PUR repeat III relative to the intramolecular domain formed by PUR repeats I 
and II (Figure 3-3C). Consequently, dimerization may occur via formation of an 
intermolecular PUR domain composed of two self-associating PUR III repeats from two 
Pur! monomers (Figure 3-3D).  
Structural analysis of computationally-derived Pur!  subdomains. To test the 
models in Figure 3-3, a series of cDNAs were engineered to encode NHis-tagged Pur! 
truncation proteins corresponding to individual PUR repeat modules (Pur! I, Pur! II, 
Pur! III) or selected combinations thereof (Pur! I-II, Pur! II-III, Pur! I-II-III). The utility 
of recombinant NHis-Pur! as a reliable experimental surrogate for the native protein 
expressed in mammalian cells has been documented in previous studies (29, 37, 56). 
Sequence validated bacterial expression plasmids were transformed into E. coli cells and 
recombinant truncation proteins were produced for trial purification under both native 
and denaturing conditions. While metal chelate affinity enrichment of each Pur! 
truncation protein was possible under harsh denaturing conditions (data not shown), only 
Pur! I-II-III (residues 41-303), Pur! I-II (residues 41-210), and Pur! III (residues 209-
303) were amenable to purification in non-denaturing solvents (Figure S3-6) and were 
found to exhibit CD spectra consistent with well-folded polypeptides (Figure S3-7). 
Hence, it appeared that Pur! I (residues 41-112), Pur! II (residues 125-210), and Pur! II-
III (residues 125-303) were intrinsically unstable and/or mis-folded when expressed in E. 
coli. This observation is consistent with the putative requirement for intramolecular 
association of PUR repeats I and II or intermolecular association of two PUR III repeats 
to form a stably-folded subdomain (Figure 3-3). To confirm the predicted quaternary  
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Figure 3- 3. Computational models of Mm Pur! monomer and dimer. (A) The primary 
sequence of the 324 amino acid Mm Pur! was analyzed by HHrepID. Predicted regions 
corresponding to PUR repeats I, II, and III are highlighted in red, blue, and green, 
respectively. Numbers refer to amino acid positions. Intervening elements and N-and C-
terminal regions are shown as black lines. (B) Web servers (I-TASSER and SWISS-
MODEL) were used to generate a homology model of the Pur! monomer. In this 
hypothetical model, PUR repeat III (140) is in a closed conformation relative to the 
intramolecular PUR domain formed by PUR repeats I (red) and II (blue). (C) A model of 
the Pur! monomer in an extended conformation was generated by rotating the PUR 
repeat III away from the intramolecular domain formed by PUR repeats I-II. (D) A model 
of the Pur! dimer was created by aligning the PUR III repeats of two Pur! monomers in 




Figure 3- 4. Quaternary structure of isolated Pur! subdomains. (A-C) Calibrated SEC 
was conducted on preparations of Pur! I-II-III (A), Pur! I-II (B), and Pur! III (C) at 
loading concentrations in excess of 10 µM (open circles). The elution profile of a mixture 
of molecular weight standards is shown for comparison (closed circles). Numbers in (A) 
indicate the apparent molecular weights of the four globular protein standards used in 
generating a standard curve to calculate the size of the Pur! species eluting in the peak 
fractions.  
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state of each isolated truncation protein, calibrated SEC was performed using loading 
concentrations well in excess of the reported Kd for the full-length Pur! dimer (36). As 
shown in Figure 3-4A and B, Pur! I-II-III eluted as a ~64 kDa dimer while Pur! I-II 
resolved as a ~18 kDa monomer. In agreement with its predicted role in mediating self-
association, Pur! III eluted as a ~17 kDa dimer (Figure 3-4C).  
ACTA2 repressor activity of Pur!  subdomains. To assess the functional role of 
each putative Pur! subdomain in ACTA2 repression, transient co-transfection assays were 
performed in MEFs and primary mouse AoSMCs using a full-length ACTA2 construct 
(#1070 to +2582, VSMP8-Luc) as well as a minimal MCAT/CArG/GC box-dependent 
enhancer (#146 to +46, VSMP4-Luc) as specific transcriptional targets of Pur! (30). As 
shown in Figure 3-5B, full-length Pur! and the core I-II-III construct demonstrated 
comparable repressor activity toward both ACTA2 reporters in MEFs. Importantly, Pur! 
I-II was the only other truncation protein to exhibit statistically significant repressor 
activity. Pur! III alone showed no inhibitory activity while Pur! II-III was only weakly 
repressive. In agreement with E. coli expression and purification studies, immunoblotting 
of non-denatured MEF lysates indicated stable expression of full-length Pur!, Pur! I-II-
III, Pur! I-II, and Pur! III (Figure 3-5C). However, Pur! I, Pur! II, and Pur! II-III were 
either not readily detected or only seen after extracting detergent-insoluble cell remnants 
with a denaturing solvent (Figure 3-5D), again pointing to the intrinsic instability and/or 
mis-folding of these truncation mutants. Essentially identical results were obtained in co-
transfection studies conducted with primary AoSMCs (Figure S3-8) supporting the 
conclusion that the relative ACTA2 repressor activity of the stably-expressed truncation  
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Figure 3- 5. ACTA2 repressor activity of Pur! truncation proteins expressed in AKR-2B 
MEFs. (A) Schematic representation of the full-length (VSMP8-Luc) and truncated 
(VSMP4-Luc) ACTA2 promoter-reporter constructs used to assess Pur! repressor 
function. PE32 designates the Pur! recognition sequence containing an MCAT motif. (B) 
Subconfluent AKR-2B MEFs were transiently co-transfected with ACTA2 luciferase 
reporters and expression vectors encoding the indicated Pur! proteins. After 48 h, cell 
lysates were prepared and assayed for luciferase activity and total protein. Bars show 
total protein-corrected luciferase values normalized to the pCI control (defined as 1) for 
each reporter (mean ± SEM, n = 9). ***, p < 0.001 compared to pCI control for VSMP8 
(black bars) or VSMP4 (gray bars). (C) Western blotting of detergent-soluble lysates (15 
µg protein/lane) of transfected cells was performed with a mAb recognizing the N-
terminal His epitope tag present on each Pur! construct. The anti-His tag blot was 
reprobed with a GAPDH mAb as a loading control. (D) Western blotting of urea-
denatured lysates (15 µg protein/lane) of detergent-insoluble cell remnants was 
conducted with the His tag mAb. (C, D) In both immunoblots, lysates were resolved on a 
15% polyacrylamide gel. Lines and numbers on the left side designate the relative 
position and size (in kDa) of prestained protein markers. FL, full-length. 
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proteins is Pur! I-II-III > Pur! I-II >> Pur! II-III or Pur! III. Titration studies conducted 
in AKR-2B MEFs using a fixed amount of VSMP8 reporter and varying amounts of 
expression plasmid confirmed that Pur! I-II-III and Pur! I-II are quantitatively distinct in 
terms of their ACTA2 repressor activity (Figure 3-6).  
Cis-element binding properties of Pur!  subdomains. To assess whether the 
relative ACTA2 repressor activity of each Pur! truncation protein correlated with 
differences in the affinity and/or specificity for target sites in the ACTA2 promoter, 
colorimetric microplate-based assays were used to compare the ssDNA-binding 
properties of Pur! I-II-III, Pur! I-II, and Pur! III to full-length Pur!. The purine-rich 
sense strand of the 5) ACTA2 Pur/Pyr element containing a consensus core MCAT motif 
(italics)  (GGGAGCAGAACAGAGGAATGCAGTGGAAGAGA, PE32-F) was chosen 
as a probe because it has multiple interacting binding sites (underlined) that permit 
formation of a high-affinity (macroscopic Kd ~ 0.3 nM) 2:1 Pur!:ssDNA complex (37). 
Initially, a titration experiment was performed to identify a minimal concentration of 3) 
biotinylated PE32-F probe necessary to detect the interaction of each Pur! truncation 
protein by ELISA. Surprisingly, stable formation of Pur! I-II nucleoprotein complexes 
required a markedly higher concentration of ssDNA implying a significant difference in 
binding affinity of the monomeric subdomain relative to full-length Pur!, Pur! I-II-III, 
and Pur! III (Figure S3-9A). Titration assays conducted with a limiting concentration of 
PE32-bF (0.5 nM) highlighted the striking differences in the apparent ssDNA-binding 
affinity of the individual subdomains, Pur! III (EC50 = 1.80 ± 0.74 nM, n = 4) and Pur! 




Figure 3- 6. Relative ACTA2 repressor activity of Pur! truncation proteins expressed in 
AKR-2B MEFs. (A) AKR-2B MEFs were transiently co-transfected with a fixed amount 
of ACTA2 luciferase reporter (VSMP8) and varying amounts of expression vector 
encoding the indicated Pur! proteins. After 48 h, cell lysates were prepared and assayed 
for luciferase activity and total protein. Symbols show total protein-corrected luciferase 
values normalized to the pCI control (mean ± SEM, n = 6). (B) Immunoblots of 
transfected cell lysates (15 µg protein/lane) with a His tag mAb (top panel) followed by a 
GAPDH mAb (lower panel). Lines and numbers on the left side designate the relative 
position and size (in kDa) of prestained protein markers. FL, full-length.  
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and Pur! I-II-III (EC50 = 0.22 ± 0.05 nM, n = 4) (Figure 3-7A and B). Consistent with a 
functional distinction between the separated dimerization and intramolecular subdomains, 
competition assays revealed that Pur! III (IC50 = 46 ± 15 nM, n = 3) and Pur! I-II (IC50 
> 1000 nM) were much less effective than the composite Pur! I-II-III construct (IC50 = 
1.0 ± 0.3 nM, n = 5) or the full-length protein (IC50 = 1.2 ± 0.2 nM, n = 5) at inhibiting 
the interaction of 0.5 nM PE32-bF with immobilized Pur! (Figure 3-7C). Despite these 
substantial differences in apparent ssDNA-binding affinity, the isolated Pur! III and Pur! 
I-II subdomains retained similar binding site specificity as demonstrated by their reduced 
interaction with mutant versions of PE32-bF containing heptathymidylate substitutions 
(T7) in place of 5)or 3) PUR and/or internal MCAT motifs (Figure 3-7D and Figure S3-
9B). 
Trans-acting factor binding properties of Pur!  subdomains. To ascertain whether 
the isolated subdomains exhibited similar protein binding properties as full-length Pur!, 
an ELISA-based profiling assay was conducted using nuclear extract of AKR-2B MEFs 
as a natural source of potential Pur! interaction partners. Recombinant Pur! proteins 
were immobilized on microtiter wells at a saturating coating concentration (200 nM) and 
then assayed for their ability to capture specific transcription factors implicated in ACTA2 
activation or repression. Consistent with previous findings (30, 56), full-length Pur! 
demonstrated preferential interaction with its co-repressor partner MSY1 relative to other 
factors screened using this assay format (Figure 3-8). Interestingly, Pur! I-II-III exhibited 
an even greater binding capacity for MSY1, while the isolated Pur! I-II and Pur! III 
subdomains displayed markedly reduced interaction with MSY1. In contrast, Pur! I-II 
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showed a clear preference for interaction with the ACTA2 trans-activator Sp3, while Pur! 
III exhibited little or no Sp3 binding activity. Essentially identical results were obtained 
using nuclear extract diluted in binding buffer supplemented with reducing agent (Figure 
S3-10). This was done to ensure that the differences observed in the binding properties of 
individual Pur! truncation proteins were not attributable to anomalous protein oxidation. 
 121 
 
Figure 3- 7. The relative affinity and specificity of Pur! truncation proteins for ssDNA. 
(A, B) Varying concentrations of the indicated NHis-Pur! proteins were incubated with 
0.5 nM biotinylated mouse ACTA2-derived ssDNA probe (PE32-bF) immobilized on 
StreptaWells. (A) Solid-phase nucleoprotein complexes were detected by ELISA using a 
primary antibody recognizing the NHis tag. Absorbance values at 405 nm (A405) were 
corrected for nonspecific binding by subtracting the signal generated in wells with no 
DNA. (B) Solid-phase nucleoprotein complexes were detected by ELISA using a primary 
antibody directed against amino acids 210-229 of Pur!. A405 values were corrected for 
nonspecific binding and normalized to the absorbance obtained at the maximum 
concentration of each protein tested (defined as 1). (C) Varying concentrations of fluid-
phase Pur! proteins were incubated with a fixed concentration of PE32-bF (0.5 nM) in 
microtiter wells pre-coated with full-length Pur! (20 nM). Solid-phase nucleoprotein 
complexes were detected by colorimetric assay using an avidin-peroxidase conjugate. 
A405 values were normalized to the maximum absorbance obtained in the absence of any 
competitor. (A, B, and C) Data points were fit to a four parameter equation to determine 
an EC50 (A, B) or IC50 (C) for each protein. A representative experiment is shown in 
each panel. (D) A fixed concentration of Pur! protein was incubated with wild type or 
mutant ssDNA probes immobilized on StreptaWells. The ratio of Pur! to ssDNA tested 
(nM/nM) is indicated in parentheses. Solid-phase nucleoprotein complexes were detected 
by ELISA with a primary His tag antibody. A405 values were corrected for nonspecific 
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binding and normalized to the absorbance obtained for each protein binding to the wild 




Figure 3- 8. Relative binding of AKR-2B MEF-derived transcription factors to purified 
NHis-Pur! proteins. Microtiter wells coated with equivalent concentrations of the 
indicated Pur! proteins (200 nM) were incubated with a fixed amount of nuclear protein 
(250 µg/ml) diluted in binding buffer. Solid-phase protein-protein complexes were 
detected by ELISA using primary rabbit polyclonal antibodies recognizing Pur", MSY1, 
TEF1, SRF, Sp3, or Sp1. Absorbance values at 405 nm generated with each transcription 
factor antibody were corrected for nonspecific antibody binding to Pur! coated wells in 
the absence of nuclear extract. Signal generated in Pur!-coated wells incubated with 
nuclear extract and probed with the secondary antibody only (no 1° Aby) is shown as a 
background control. FL, full-length.  
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DISCUSSION 
The transient differentiation of stromal fibroblasts to contractile, SM"A-expressing 
myofibroblasts is an essential and tightly-regulated component of the wound healing 
process. Conversely, sustained stromal myofibroblast activation is pathologic as it often 
promotes aberrant tissue remodeling (61). Because SM"A expression is a biochemical 
hallmark of the myofibroblast phenotype, a better understanding of the regulatory factors 
that mediate ACTA2 transcription and translation in fibroblasts may reveal novel targets 
for therapeutic intervention to limit destructive fibrocontractile remodeling associated 
with scarring, fibrosis, and tumor progression. Among the factors implicated in ACTA2 
regulation in fibroblasts, Pur" and Pur! are unique in that they apparently repress gene 
transcription by forming nucleoprotein complexes with purine-rich ssDNA in such a way 
as to block trans-activator recognition of cognate double-stranded binding sites within 
the composite MCAT/CArG/GC box enhancer (16, 17, 30, 62).  
In view of a growing body of evidence suggesting that Pur! may play a central role in 
repressing genes encoding muscle-restricted isoforms of actin and myosin in both 
myogenic and non-myogenic cell types (31-35), we initially sought to confirm that 
deficiency of Pur! in MEFs would necessarily promote the acquisition of a myofibroblast 
phenotype in vitro. To do so, we transduced MEFs using a lentivirus-based shRNA 
transgene delivery system to knockdown the expression of Pur! in a specific, stable, and 
constitutive manner. Analyses of two independently-derived cell lines showed that a 
relatively modest decrease in Pur! expression (~60-70% knockdown) was sufficient to 
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switch cells to a myofibroblast-like phenotype as exemplified by characteristic changes in 
cell morphology, SM"A expression, TGF-!1 inducibility, and chemotactic migration 
(Figures 3-1, 3-2, S3-3 and S3-4). Importantly, these changes occurred in the absence of 
any substantive effect on cell growth suggesting that Pur! does not participate in the 
direct regulation of cell cycling as has been reported for Pur" (63-68).  
To better understand the structural basis for Pur!-mediated repression of ACTA2, we 
employed web-based homology modeling servers to generate computational models of 
the Pur! monomer and dimer based on the known x-ray crystal structure of Dm Pur" 
residues 40-185 (39). As previously described for Pur" (38), the HHrepID web server 
identified three regions of internal sequence homology termed PUR repeats I, II, and III 
(Figure 3-3). Homology modeling suggested that each PUR repeat is similarly structured 
with respect to the arrangement of four !-stands and one "-helix. By analogy to the 
tertiary structure of Dm Pur" I-II, Mm Pur! I-II is predicted to fold in such a way as to 
form an intramolecular PUR domain with features resembling a Whirly class-like DNA-
binding fold (39). Although the PUR III repeat of Pur! is also predicted to adopt !!!!" 
topology, the "-helical region is substantially longer than in PUR repeats I and II owing 
to the presence of the so-called “psycho” motif spanning residues 264-305 (29). This 
sequence is predicted to form an extended amphipathic "-helix, which may facilitate 
protein-protein interaction. In one hypothetical model of the Pur! monomer, the PUR III 
repeat is depicted as packing against the PUR I-II intramolecular domain (Figure 3-3B). 
However, previous hydrodynamic studies showed that full-length Pur! reversibly self-
associates to form an elongated homodimer (36). Therefore, we speculated that the 
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glycine-rich sequence spanning residues 210-229 may impart some degree of internal 
flexibility allowing the PUR III repeat region to extend away from I-II (Figure 3-3C). 
The interaction of two PUR III repeats to form an intermolecular PUR domain would 
necessarily give rise to an elongated Pur! homodimer composed of three distinct modules 
(Figure 3-3D).  
Based on these deduced homology models, we created a set of expression vectors 
encoding His-tagged Pur! truncation proteins containing single or selected combinations 
of PUR repeats I, II, and III. Trial purifications from E. coli indicated that stable 
expression and folding of Pur! requires the formation of intra- and/or intermolecular 
subdomains. For example, Pur! I, Pur! II, and Pur! II-III constructs were poorly 
expressed and/or only detectable in denatured lysates. Conversely, full-length Pur!, Pur! 
I-II-III, Pur! I-II, and Pur! III were each highly expressed and readily purified under 
non-denaturing conditions. Moreover, their respective CD spectra were indicative of 
well-folded polypeptides. The results of calibrated SEC analysis confirmed the predicted 
quaternary state of each purified truncation protein and indicated that PUR repeat III 
constitutes the dimerization domain of Pur! (Figure 3-4). These findings are entirely 
consistent with the reported quaternary structures of Dm Pur" I-II and Dm Pur" I-II-III 
(39). Although the Pur" homodimer has been proposed to adopt a Z-like shape based on 
results of small angle-X-ray scattering (39), the exact orientation and relation of the intra- 
and intermolecular subdomains in the Pur! homodimer is currently unknown.  
To evaluate the capacity of each Pur! truncation protein to repress ACTA2 
transcription, we performed ACTA2-luciferase reporter gene assays in both MEFs and 
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AoSMCs. As expected, the relative expression/stability of each Pur! construct in 
mammalian cells was similar to that seen in E. coli. Of the truncation proteins expressed, 
only the dimerization-competent Pur! I-II-III core construct and the Pur! I-II 
intramolecular subdomain were consistently found to repress both the complete and 
minimal ACTA2 enhancer-promoter in both cell types (Figures 3-5 and S3-8). However, 
while Pur! I-II-III repressed the promoter to the same extent as the full-length protein, 
Pur! I-II exhibited ~50% less repressor activity. The intrinsically weaker activity of Pur! 
I-II was validated by titration experiments conducted over an extended range of 
expression vector concentrations pointing to the necessity of the PUR III repeat for full 
repressor function (Figure 3-6). Interestingly, forced expression of the Pur! III 
dimerization domain by itself did not affect the ACTA2 enhancer-promoter owing, in part, 
to the apparent inability of this construct to enter the nucleus when separated from Pur! 
I-II intramolecular domain (Figure S3-11). However, in the context of the full-length 
protein and the Pur! I-II-III core construct, we surmise that the PUR repeat III likely 
promotes more efficient ACTA2 repression by mediating the formation of a dimeric 
repressor capable of multisite ssDNA-binding within the confines of the nucleus.  
Previous high resolution structural analyses of the 5)-flanking region of ACTA2 
during myofibroblast differentiation revealed that an asymmetric Pur/Pyr tract spanning 
nucleotides #210 to #150 is hypersensitive to modification by chemical probes that 
preferentially react with unpaired nucleobases (58). This region contains a consensus 
MCAT motif and a TGF-!1 response element that appear to function in conjunction with 
downstream CArG and GC boxes to mediate high level ACTA2 transcription in 
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fibroblasts (16, 17, 20). Consequently, we have chosen to focus our efforts on 
characterizing the interaction of Pur! with the MCAT region of the ACTA2 enhancer-
promoter due to its high Pur/Pyr asymmetry and apparent propensity to transiently adopt 
non B-form structures in vivo (58). In this regard, a prior study from our lab reported that 
Pur! interacts with the 32 nt purine-rich strand of the ACTA2 MCAT element (dubbed 
PE32-F, #195 to #164) via a cooperative binding mechanism to generate a high-affinity 
2:1 Pur!:ssDNA complex (37).  
To test the importance of protein dimerization in facilitating the interaction of Pur! 
with PE32-F, the relative ssDNA-binding affinity and specificity of full-length Pur! and 
the core I-II-III protein were compared to the isolated intra- and intermolecular 
subdomains using both direct and competitive ssDNA-binding assays. Because these 
microplate-based colorimetric assays were performed under intrinsically non-equilibrium 
conditions, it was not possible to determine precise quantitative differences between Pur! 
I-II-III and the full-length protein. Despite this technical limitation, the Pur! I-II-III core 
construct did appear to bind PE32-F with comparable affinity and specificity to full-
length Pur! under the assay conditions employed (Figure 3-7). Moreover, the 
biochemical properties of Pur! I-II-III (residues 41-303) defined in this study are 
analogous to those of a His tag-free core tryptic fragment of Pur! (residues 29-305) 
described in an earlier report (40). Interestingly, while the Pur! I-II and Pur! III 
subdomains each displayed a lower apparent affinity for PE32-F than Pur! I-II-III, the 
intermolecular subdomain bound more tightly to ssDNA than the intramolecular 
subdomain. The functional non-identity of the isolated Pur! I-II and Pur! III subdomains 
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suggests that the native Pur! homodimer contains three separate but unequal ssDNA-
binding modules. This structural arrangement reinforces the concept that stable 
nucleoprotein complex assembly on the ACTA2 MCAT element likely involves the 
recognition of multiple binding sites by Pur! (37). In support of this assertion, mutation 
of all three PUR elements in PE32-F was necessary to completely eliminate ssDNA-
binding by full-length Pur!, the I-II-III core, and each subdomain (Figure 3-7D).  
Another defining attribute of Pur! structure and function uncovered in this report is 
that the individual subdomains of Pur! differ in their capacity to interact with certain 
transcription factors relevant to ACTA2 regulation in fibroblasts. In particular, the Pur! I-
II intramolecular subdomain was a more avid binder of Sp3 than the Pur! III 
intermolecular subdomain (Figure 3-8 and Figure S3-10). As Sp1 and Sp3 are known to 
interact with several sequence elements located within the composite MCAT/CArG/GC 
box enhancer (20), it is quite possible that the relatively strong repressor activity of Pur! 
I-II observed in transfected cells was due, in part, to its ability to bind and sequester Sp3 
away from the enhancer. This would also explain why Pur! I-II retained repressor 
activity in the face of its relatively weak ssDNA-binding affinity compared to Pur! I-II-
III. On the other hand, all three PUR repeats were required for efficient interaction of 
Pur! with MSY1 (mouse YB-1), the co-repressor protein that interacts with the 
pyrimidine-rich antisense strand of the ACTA2 Pur/Pyr tract (17, 22). This feature may 
account for why Pur! I-II-III was such an effective repressor when expressed in cells as 
direct physical interaction between Pur! and MSY1 is probably essential for efficient 
assembly of these co-repressors on the Pur/Pyr element and ensuing disruption of the 
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core MCAT motif (37). Coordinated binding of MSY1 to the pyrimidine-rich strand may 
also serve to potentiate the intrinsic helix-destabilizing activity of Pur! (28). Unraveling 
the degree to which Pur! can stably alter the secondary structure of specific cis-elements 
in ACTA2 will clearly require a more systematic evaluation of the helix-destabilizing 
properties of Pur! and its isolated subdomains based on the biochemical criteria 
established for Pur"-mediated melting of duplex DNA (27, 28, 69). 
In summary, our findings reveal that Pur! is a potent inhibitor of myofibroblast 
differentiation by virtue of its ability to repress ACTA2 transcription via specific protein-
ssDNA and protein-protein interactions. The functionally relevant unit of Pur! that 
mediates ACTA2 repression appears to be the homodimeric form of the protein. 
Subdomain-specific inter- and intramolecular interactions account for the formation of 
three separate ssDNA-binding modules within the Pur! homodimer. The tripartite 
organization of the assembled homodimer readily explains the structural basis for the 
cooperative binding of Pur! to multiple purine-rich sites within the MCAT region of the 
composite ACTA2 enhancer as well as the preferential association of Pur! with its co-
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Construction of expression vectors encoding Pur!  truncation proteins. 
Complementary DNAs encoding amino acids 41-112 (Pur! I), 125-210 (Pur! II), 209-
303 (Pur! III), 41-210 (Pur! I-II), 125-303 (Pur!  II-III), and 41-303 (Pur! I-II-III) were 
amplified by polymerase chain reaction (PCR) from the pCI-10-1Pur! template (1) using 
Pfu polymerase (Stratagene) and primers engineered to create 5) BamHI and 3) KpnI 
cloning sites (Table S3-I). PCR products were gel purified, cut with restriction enzymes, 
and ligated into BamHI/KpnI digested and alkaline phosphatase-treated pQE30 vector 
(Qiagen). Following transformation into E. coli JM109 cells, ampicillin-resistant clones 
were selected and bacterial expression plasmids were purified from 5 ml cultures using a 
High Pure Plasmid Isolation Kit (Roche Applied Science). Plasmids were screened for 
the presence of the correct cDNA insert by restriction enzyme digestion and DNA 
sequencing. EcoRI/KpnI fragments were then isolated from sequence-validated pQE30 
constructs and subcloned into EcoRI/KpnI digested and alkaline phosphatase-treated pCI 
vector (Promega). The resulting mammalian expression plasmids were propagated in E. 
coli DH5" cells and screened for insertion and sequence fidelity as described above. 
DNA sequencing of plasmid constructs was performed by the Vermont Cancer Center 
DNA Analysis Facility.  
All reporter and expression plasmids used in transient transfection studies were 
purified from 1 liter E. coli cultures by double CsCl gradient centrifugation. Ethidium 
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bromide was extracted from isolated plasmid bands using 50% v/v CsCl-saturated 
isopropanol. Plasmids were then dialyzed extensively against 7.5 mM sodium citrate, 75 
mM NaCl pH 7.0, precipitated with 70% ethanol, and collected by centrifugation. 
Plasmid pellets were washed with 70% ethanol and then dissolved in sterile water. 
Soluble plasmids were quantified by optical density measurement and stored at #20°C. 
Relative DNA purity was assessed by A260/A280 ratio in conjunction with agarose gel 
electrophoresis of supercoiled and restriction enzyme cut plasmids.  
Cell growth assay. AKR-2B MEF cell lines were seeded at a fixed density of 2.0% 
105 cells per 60 mm dish in McCoys 5A medium with 5% FBS and 10 µg/ml blasticidin. 
At selected time points, cells were trypsinized, resuspended in serum-containing growth 
medium, and enumerated using a hemacytometer. Counts were typically performed on 
two dishes of cells at each time point and repeated three times.  
Cell migration assay. Stably-transduced AKR-2B MEF cell lines were grown to 
confluence in growth medium containing 10 µg/ml blasticidin and then switched to 
serum-free medium for 24 h. Cells were then trypsinized, resuspended in trypsin-
neutralization solution (Lonza), and counted. Cells were collected by centrifugation at 
450 % g for 10 min and resuspended in serum-free MCDB-402 medium (JRH 
Biosciences) to a concentration of 2.5 % 106 cells/ml. A total of 0.1 ml was loaded (in 
duplicate or triplicate) into 6.5 mm diameter, 8.0 µm pore size Transwell& inserts 
(Corning Costar Corp.), which were placed in wells containing 0.6 ml of MCDB-402 
medium supplemented with 10% v/v FBS or 5% w/v BSA for 22 h at 37°C in a 5% CO2 
incubator. Inserts were washed with PBS and transferred to wells containing 0.09% w/v 
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crystal violet in 8% v/v ethanol, 1% v/v methanol, 1% v/v isopropanol for 30 min. The 
cell-stained inserts were rinsed extensively in water and the inner membrane of each 
insert was cleaned with a cotton fiber-tipped swab prior to air-drying for 30 min. The 
inserts were then placed in wells containing 0.2 ml cell extraction solution consisting of 
0.2 M acetate pH 5.0, 45% v/v ethanol, 3% v/v methanol, 3% v/v isopropanol. Cell 
lysates, 0.1 ml, were transferred to 96-well plates and absorbance values at 570 nm were 
obtained using a microplate reader.  
Expression and purification of recombinant Pur!  truncation proteins. Amino-
terminal hexahistidine-tagged (NHis) fusion proteins were expressed in E. coli JM 109 
cells transformed with pQE30 plasmids encoding full-length mouse Pur", mouse Pur!, or 
selected Pur! truncation proteins. Terrific broth containing 100 µg/ml ampicillin 
(typically 4 liters) was inoculated with a 1:50 dilution of bacterial starter culture. After 3 
h growth in a 37°C shaker incubator, full-length NHis-Pur! or NHis-Pur! I-II expression 
was induced by the addition of 1 mM isopropyl !-D-1-thiogalactopyranoside (IPTG) for 
4 h at 37°C. Stable expression of NHis-Pur! I-II-III or NHis-Pur! III was achieved by 
addition of 0.1 mM IPTG and incubating for 16 h at 25°C. Cells were collected by 
centrifugation at 8000 % g for 10 min at 4°C and soluble lysate was prepared as described 
previously (2). Recombinant truncation proteins were purified by metal chelate affinity 
chromatography (His-Select& Nickel Affinity Gel, Sigma-Aldrich) followed by size 
exclusion chromatography (SEC) using conditions previously established for full-length 
NHis-Pur! with some modifications (2). Briefly, His-tagged proteins were eluted from 
the Nickel Affinity Gel by application of a linear gradient of 10 to 500 mM imidazole in 
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column buffer consisting of 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM !-
mercaptoethanol, 0.5 mM PMSF, and 1 µg/ml each of aprotinin, pepstatin A, and 
leupeptin. Elution was monitored by measuring the absorbance of fractions at 280 nm. 
Fractions enriched in recombinant protein as determined by SDS-PAGE were pooled and 
concentrated using either a 10,000 MWCO (NHis-Pur! I-II-III) or 3,500 MWCO (NHis-
Pur! I-II and NHis-Pur! III) Amicon& Ultra centrifugal filter unit (Millipore). SEC of 
NHis-Pur! truncation proteins was performed on a calibrated 1.5 % 100 cm column 
packed with Sephacryl& 200 HR resin (Sigma) at a flow rate of 0.85 ml/min. NHis-Pur! 
I-II-III was subjected to an additional heparin-agarose affinity purification step prior to 
SEC in a similar manner as described for the Pur! core tryptic fragment (3).  
Antibody screening assays. Mouse or rat antiserum and hybridoma culture 
supernatants were screened by enzyme-linked immunosorbent assay (ELISA). Bovine 
serum albumin (BSA)-coupled peptides at 1.0 µM or full-length recombinant Pur" or 
Pur! at 50 nM were passively absorbed to microtiter wells (Costar& EIA/RIA plates or 
strips, Corning Inc.) in 100 µl coating buffer consisting of 20 mM Tris-Cl pH 7.5, 150 
mM NaCl (TBS) with 5 µg/ml BSA. After overnight incubation at 4°C, coating solution 
was removed and the wells were rinsed twice with wash buffer consisting of TBS with 
0.05% v/v Tween& 20 (TBST) followed immediately by the addition of 300 µl of 2% 
w/v BSA-TBS blocking buffer. After 1 h incubation at ambient temperature, blocking 
buffer was removed and 100 µl of hybridoma culture supernatant or rodent antiserum 
diluted serially in 0.2% w/v BSA-TBST was applied. Uncoated, BSA-blocked wells 
served as a negative control. After 2 h incubation with primary antibody, wells were 
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washed three times and 100 µl of a 1:4000 to 1:8000 dilution of horseradish peroxidase 
(HRP)-conjugated goat anti-mouse IgG (Jackson Laboratories or Santa Cruz 
Biotechnology, Inc.) or HRP-conjugated goat anti-rat IgG (Santa Cruz Biotechnology, 
Inc.) was applied for 1 h. After removing the secondary antibody, the wells were washed 
three times and 100 µl of ABTS (2,2)-AZINO-bis[3-ethylbenziazoline-6-sulfonic acid]) 
peroxidase substrate solution (Millipore) was applied. The reaction was quenched by the 
addition of an equal volume of 1% w/v sodium dodecyl sulfate solution and absorbance 
values at 405 nm were obtained using a 96-well plate reader. Color development times 
typically ranged from 8 to 15 min.  
Western blotting antibodies. The source and dilution of primary antibodies used for 
immunoblotting were as follows: rabbit anti-Pur"/! B42-69 ((4), 1.0 µg/ml), rat anti-
Pur"/! clone 3C3.6C1 (this report, 0.5 µg/ml), mouse anti-smooth muscle "-actin clone 
1A4 (Sigma-Aldrich, 1:2000), mouse anti-!-actin clone AC-15 (Sigma-Aldrich, 1:2000), 
mouse anti-GAPDH clone 6C5 (Millipore, 1.0 µg/ml), mouse anti-RGS-His (Qiagen, 1.0 
µg/ml). HRP-coupled goat anti-mouse IgG, goat anti-rabbit IgG, or goat anti-rat IgG 







SUPPLEMENTAL TABLE AND FIGURES 
 
Table S3- 3 Primer sets used in the amplification of cDNAs encoding mouse Pur!  
truncation proteins containing sequences corresponding to PUR repeats I, II, or III 
_______________________________________________________________________
 Primersa     Sequenceb 
_______________________________________________________________________ 
Pur! I (41-112): 
 
mPurb RI 41S    5)-ATCATGGGATCCCAGGAGACGCAGGAGCTGGCCTCG-3) 
mPurb RI 112AS    5)-CATGATGGTACCTTAGCTGGGACCCAGCTGCGCGTA- 3) 
 
Pur! II (125-210): 
 
mPurb RII 125S      5)-ATCATGGGATCCGGCGGGCCGCGCCGCGCGCTCAAG-3) 
mPurb RII 210AS   5)-CATGATGGTACCTTAGTCCTCGTCGCCCCCGTAGTC-3) 
 
Pur! III (209-303): 
 
mPurb RIII 209S    5)-ATCATGGGATCCGAGGACGAGCTGGCCGGCGGCCCG-3) 
mPurb RIII 303AS 5)-CATGATGGTACCTTAGTAAAGCTTATCCCTCTGTCG-3) 
 
Pur! I-II (41-210): 
 
mPurb RI 41S    5)-ATCATGGGATCCCAGGAGACGCAGGAGCTGGCCTCG-3) 
mPurb RII 210AS   5)-CATGATGGTACCTTAGTCCTCGTCGCCCCCGTAGTC-3) 
 
Pur! II-III (125-303): 
 
mPurb RII 125S      5)-ATCATGGGATCCGGCGGGCCGCGCCGCGCGCTCAAG-3) 
mPurb RIII 303AS  5)-CATGATGGTACCTTAGTAAAGCTTATCCCTCTGTCG-3) 
 
Pur! I-II-III (41-303): 
 
mPurb RI 41S     5)-ATCATGGGATCCCAGGAGACGCAGGAGCTGGCCTCG-3) 
mPurb RIII 303AS  5)-CATGATGGTACCTTAGTAAAGCTTATCCCTCTGTCG-3) 
_______________________________________________________________________ 
aNumbers in parentheses denote the amino acid sequence encoded by the cDNA  
amplified by each primer set (not including the N-terminal His epitope tag).  
Abbreviations: m, mouse; S, sense; AS, antisense. 
bClamp, BamHI site (sense primer), KpnI site (antisense primer), TTA (stop codon) 
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Figure S3- 1. Characterization of monoclonal antibodies recognizing Pur" and Pur!. 
Microtiter wells coated with an equivalent concentration of NHis-Pur" (A) or NHis-Pur! 
(B) were incubated with varying amounts of the indicated mouse or rat monoclonal 
antibodies. Solid-phase antibody-Pur"/! complexes were detected by ELISA. Antibodies 
raised against amino acids 42-69 of Pur! (PURB42, a PUR repeat I sequence conserved 
in Pur") recognize both Pur" and Pur! while antibodies raised against C-terminal amino 
acids 302-324 of Pur! (PURB302) only recognize Pur!. Due to its very high affinity for 
both Pur" and Pur!, mAb 3C3.6C1 was chosen for use in Western blotting analyses.  
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Figure S3- 2. Growth of stably-transduced AKR-2B MEF cell lines. Cells were seeded at 
a fixed density of 2.0 % 105 cells per 60 mm dish in McCoys 5A medium supplemented 
with 5% FBS and 10 µg/ml blasticidin. Cell counts were performed every 24 h. Bars 
(mean ± SEM, n = 8) show cell counts performed on Pur! knockdown MEFs (!I-B4, 
black bars), Pur" deficient MEFs (!I-F3, red bars), or scrambled RNA control cells (!S-
E6, green bars). 
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Figure S3- 3. Morphology of Pur! knockdown MEFs at confluence. (A) Immunoblotting 
of whole cell extracts (15 µg protein/lane) of the indicated MEFs cell lines was 
conducted with rat anti-Pur"/! mAb 3C3.6C1. The Pur"/! blot was reprobed with a 
GAPDH mAb as a protein loading control. !I-B4 and !I-G7 are cell lines stably 
expressing Pur! shRNA, while !S-E6 is a control cell line expressing scrambled RNA. 
!I-F3 is a serendipitously isolated cell line that exhibits markedly reduced Pur" 
expression. Lines and numbers on the left side designate the relative position and size (in 
kDa) of prestained protein markers. (B) Phase contrast micrographs of confluent cultures 
of the indicated MEF cell lines viewed through a 10% objective. 
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Figure S3- 4. Relative migration of Pur! knockdown MEFs. The migration of the Pur! 
knockdown (!I-B4 and !I-G7) and control (!S-E6) MEFs toward chemotactic agent 
(10% FBS) or inert medium (5% BSA) was assessed by colorimetric Boyden chamber 
assay. Bars shows the absorbance values at 570 nm (A570) of extracts made from post 
migration, crystal violet-stained cells (mean ± SEM, n = 11 for 10% FBS and n = 7 for 
5% BSA). **, p < 0.01, ***, p < 0.001 compared to !S-E6.  
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Figure S3- 5. Hypothetical structure of PUR repeats I and II in Pur" versus Pur!. The 
known structure of Dm Pur" 40-185 (A, blue) was used as a template to generate 
homology models of the intramolecular domain formed by PUR repeats I and II in Mm 
Pur" (B, green) and Mm Pur! (C, orange) using the SWISS-MODEL web server. (D) 
Predicted structures were overlaid using PyMOL to reveal several internal loop-forming 
elements that may distinguish Pur" from Pur!. The most distinctive regions within Mm 
Pur! correspond to amino acids 109-131 and 162-182. 
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Figure S3- 6. SDS-PAGE of purified Pur! truncation proteins. Recombinant proteins 
were expressed in and purified from E. coli JM109 cells using a combination of metal 
chelate affinity, heparin agarose affinity, and size exclusion chromatography. Proteins 
were separated on a 4-20% gradient gel under reducing conditions and stained with 
Coomassie Blue. Each lane was loaded with 40 pmoles of NHis-tagged protein. The 
numbers on the left side designate the relative size (in kDa) of marker proteins in the 
ladder run in lane 1. FL, full-length. 
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Figure S3- 7. Analysis of Pur! truncation proteins by CD spectroscopy. (A) Baseline-
corrected CD spectra of 5.0 µM solutions of the indicated purified recombinant proteins 
are shown. Pur! I-II #1 and #2 refer to two distinct protein preparations. (B) The mean 
residue ellipticity in deg cm2 dmol-1 of each protein at each wavelength was calculated 
using the formula [!] = !obs/(c * l * n) where !obs is the observed ellipticity in millidegrees, 
c is the molar protein concentration, l is the path length of the cuvette in millimeters, and 
n is the number of amino acid residues. The values of n for each NHis-tagged protein are 





Figure S3- 8. ACTA2 repressor activity of Pur! truncation proteins expressed in 
C57BL/6 AoSMCs. (A) Primary AoSMCs were transiently co-transfected with ACTA2 
luciferase reporters (VSMP8 or VSMP4) and expression vectors encoding the indicated 
Pur! proteins. After 48 h, cell lysates were prepared and assayed for luciferase activity 
and total protein. Bars show total protein-corrected luciferase values normalized to the 
pCI control (defined as 1) for each reporter (mean ± SEM, n = 6 to 9). ***, p < 0.001, **, 
p < 0.01, *, p < 0.05 compared to pCI control for VSMP8 (black bars) or VSMP4 (gray 
bars). (B) Western blotting of detergent-soluble lysates (10 µg protein/lane) of 
transfected cells was performed with a mAb recognizing the N-terminal His epitope tag 
present on each Pur! construct. (C) Western blotting of urea-denatured extracts (10 µg 
protein/lane) of detergent-insoluble cell remnants was conducted with the His tag mAb. 
(B, C) In both immunoblots, lysates were resolved on a 14% polyacrylamide gel. Lines 
and numbers on the left side designate the relative position and size (in kDa) of 
prestained protein markers. FL, full-length. 
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Figure S3- 9. Binding of purified NHis-Pur! proteins to PE32-bF. (A) Biotinylated 
ssDNA probe (PE32-bF) corresponding to the sense strand of a cis-element spanning 
nucleotides #195 to #164 of mouse ACTA2 was immobilized on StreptaWells at 
concentrations ranging from 60 nM to 82 pM. Solutions containing 1.0 nM of the 
indicated NHis-Pur! proteins were added and the wells were incubated for 16 h. Solid-
phase nucleoprotein complexes were detected by ELISA using a primary His tag 
antibody. Absorbance values at 405 nm were corrected for nonspecific protein binding to 
wells without DNA and normalized to the maximum absorbance attained at saturation for 
each protein. Data points were fit to a four parameter equation (Y = Amin + (Amax-
Amin)/(1+10((LogEC50-X)*HillSlope)) to determine the midpoint (EC50) of each curve. (B) 
Varying concentrations of NHis-Pur! were incubated with 5.0 nM wild type PE32-bF or 
double or triple PUR element mutants (35T7 or 3I5T7) immobilized on StreptaWells. 
Solid-phase nucleoprotein complexes were detected by ELISA using a primary His tag 
 154 
antibody. Absorbance values at 405 nm were corrected for nonspecific binding of NHis-




Figure S3- 10. Binding of AKR-2B MEF-derived transcription factors to purified NHis-
Pur! proteins. Microtiter wells coated with equivalent concentrations of the indicated 
Pur! proteins (200 nM) were incubated with a fixed amount of nuclear protein (250 
µg/ml) diluted in binding buffer containing 0.5 mM DTT. Solid-phase protein-protein 
complexes were detected by ELISA using primary rabbit polyclonal antibodies directed 
against Pur", MSY1, TEF1, SRF, Sp1, or Sp3. Parentheses indicate the specific antibody 
designation. Absorbance values at 405 nm were corrected for nonspecific antibody 
binding to Pur!-coated wells in the absence of nuclear extract. Control experiments 
conducted with a His tag antibody indicated that the coating efficiency of each Pur! 
construct was equivalent at protein coating concentrations in excess of 100 nM (data not 
shown). FL, full-length.  
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Figure S3- 11. Subcellular distribution of Pur! truncation proteins. AKR-2B MEFs were 
transiently transfected with equivalent amounts of expression vector encoding either 
NHis-Pur! I-II or NHis-Pur! III. After 48 h, adherent cells were harvested, washed, and 
processed by sequential fractionation in cytoplasm extraction buffer (CEB), membrane 
extraction buffer (MEB), nuclear extraction buffer (NEB), and nuclear extraction buffer 
plus micrococcal nuclease (NEB+). Subcellular protein fractions (30 µg loaded/lane) 
were analyzed by Western blotting with a His tag mAb. Lines and numbers on the left 
side designate the relative position and size (in kDa) of prestained protein markers. In 
contrast to the near equal distribution of Pur! I-II in cytoplasmic and nuclear fractions, 
Pur! III expression is restricted almost exclusively to the cytoplasmic compartment.  
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actin; ssDNA, single-stranded DNA; MCAT, muscle-CAT box; Sp(1/3), specificity 
protein 1 and 3; Pur", purine-rich element binding protein A; Dm, Drosophila 
melanogaster; Mm, Mus Musculus; YB-1, Y-box binding protein 1; MEF, mouse embryo 




Fibrotic diseases are characterized by a persistent fibroblast to myofibroblast 
transition marked by an increased expression of smooth muscle "-actin (SM"A). The 
SM"A gene, ACTA2, is regulated by a multifaceted network of transcriptional regulatory 
factors that activate or repress the promoter-enhancer. Purine-rich element binding 
protein B (Pur!) is a transcriptional repressor that suppresses the expression of SM"A by 
cooperatively interacting with the cryptic 5’-MCAT enhancer motif. A recent study from 
our laboratory showed that the functionally relevant Pur! homodimer is made up of an 
intermolecular subdomain flanked by two intramolecular subdomains that confer high-
affinity multisite binding to a purine-rich sequence from the ACTA2 enhancer. In this 
study, we evaluated the chemical basis of nucleoprotein complex formation between the 
Pur! repressor protein and the ACTA2 promoter. Quantitative single-stranded DNA 
(ssDNA)-binding assays conducted in the presence of increasing concentrations of 
monovalent salt or anionic detergent suggested that high affinity nucleoprotein 
interaction is driven by a combination of ionic and hydrophobic interactions. Consistent 
with results of in vitro biochemical assays, site-directed mutagenesis revealed several 
basic residues within the inter- and intramolecular subdomains (K82, R159, R267) of 
Pur! that are essential for maximal transcriptional repressor activity in cell-based ACTA2 
promoter-reporter assays. Our findings point to a combinatorial role for hydrophobic and 
ionic interactions in facilitating protein self-association, ssDNA-binding, and ACTA2 




Myofibroblasts are contractile cells with a smooth muscle-like phenotype that 
play a key role in granulation tissue formation and provide the contractile force necessary 
for wound closure during tissue repair (1-4). Although this cell-type is beneficial for 
wound healing, chronic activation and survival of myofibroblasts contributes to the 
progression of fibrotic diseases including hypertrophic scar formation, pathological 
vascular remodeling, and persistent organ fibrosis resulting in heart, liver and lung 
impairment (5-7). To develop better therapeutic strategies for treating fibrotic 
pathologies, it is necessary to identify and characterize the molecular pathways that 
govern myofibroblast growth and differentiation. 
Smooth muscle "-actin (SM"A) is a key protein biomarker of fibroblast to 
myofibroblast conversion and acquisition of a contractile phenotype (2,8-10). Expression 
of the SM"A gene (ACTA2) in fibroblasts is tightly regulated by a complex network of 
transcriptional activators and repressors (11,12). The 5’-flanking region of ACTA2 
contains a variety of positive cis-regulatory elements including an inverted muscle-CAT 
(MCAT) enhancer motif, CArG boxes, and GC-rich sequences that act as cognate 
binding sites for trans-activators transcription enhancer factor 1 (TEF-1), serum response 
factor (SRF), and specificity proteins 1 and 3 (Sp1/3), respectively (13-17). ACTA2 
transcription in fibroblasts is repressed by the coordinate interaction of purine-rich 
element bind proteins A and B (Pur" and Pur!) and Y-box binding protein (YB-1) with 
the opposing strands of a polypurine-polypyrimidine (Pur/Pyr) sequence surrounding the 
MCAT motif (14,18-20).  
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Although Pur" and Pur! both interact with purine-rich single-stranded nucleic 
acids and possess the capacity to destabilize duplex DNA, they also possess distinct 
functional properties (21-23). While gain-of-function/overexpression assays identified 
Pur! as the dominant repressor of ACTA2 in fibroblasts and smooth muscle cells, gene 
knockdown studies suggested that Pur" may function as a co-regulator of ACTA2 
expression in fibroblasts (24,25). A more recent study revealed that Pur" and Pur! differ 
in their protein-protein interaction properties during myofibroblast differentiation (26).  
 Pur" and Pur! are members of a small but highly conserved family of purine-rich 
ssDNA/RNA-binding proteins (27). Each member of the Pur family (Pur", Pur!, Pur$ 
variant A, Pur$ variant B) contains three central sequence elements designated PUR 
repeats I, II, and III (27-29). These sequences elements account for the roughly 70% 
sequence homology between mammalian Pur" and Pur! (22). Recently solved x-ray 
crystal structures of Drosophila melanogaster (61) Pur" (amino acids 40 to 185) and 
Borrelia burgdorferi (Bb) Pur" (amino acids 8 to 105) revealed that PUR repeat 
sequences fold to form a 4-standed anti-parallel !-sheet followed by an "-helix. In the 
case of Dm Pur", intramolecular association of PUR repeats I and II produces a Whirly-
like globular domain (dubbed the PUR domain) capable of ssDNA interaction (28). In the 
case of Bb Pur", intermolecular dimerization of the single encoded PUR repeat forms a 
ssDNA-binding PUR domain, which is nearly identical to the intramolecular dimer 
generated by association of PUR repeats I and II of Dm Pur" (29). Because full-length 
Pur proteins in metazoans contain three PUR repeats, PUR repeat III likely serves to 
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mediate intermolecular interaction of Pur protein monomers as first reported in Dm Pur" 
(28).  
Our efforts to establish the molecular basis for ssDNA-binding and ACTA2 
repression by Pur! have provided additional insight into the similarities and differences 
in the structural and functional properties of members Pur protein family. For example, 
hydrodynamic analyses indicated that recombinant mouse Pur! reversibly self-associates 
to form a homodimer (Kd ~ 1.0 µM) in the absence of ssDNA (30). Rigorous quantitative 
analyses of nucleoprotein complex formation between Pur! and the 32 nt purine-rich 
strand of the ACTA2 MCAT-containing Pur/Pyr element were consistent with a 
cooperative, multisite binding mechanism leading to formation of a high-affinity 2:1 
Pur!:ssDNA complex (31). Results of limited tryptic digestion suggested that the 
presence of all three PUR repeats was required for high affinity binding of Pur! to the 
purine-rich strand of the ACTA2-derived MCAT enhancer (32). To further define the 
structural elements in Pur! responsible for multisite ssDNA-binding and ACTA2 
repression in fibroblasts, we recently reported that dimeric Pur! is comprised of three 
distinct PUR subdomains each capable of ssDNA interaction (33). Consistent with the 
cooperative nature of Pur!-ssDNA interaction, all three PUR subdomains were required 
for high affinity interaction of Pur! with the ACTA2 promoter. Interestingly, when 
studied in isolation, the central dimerization subdomain of Pur! formed by intermolecular 
association of two PUR repeat III sequences exhibited markedly higher ssDNA-binding 
affinity than the comparable subdomain formed by intramolecular association of PUR 
repeats I and II (33).  
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In this report, we evaluated the detergent- and salt-sensitivity of nucleoprotein 
complex formation between Pur! and an ACTA2-derived ssDNA target sequence. Based 
on computational homology modeling of Pur! protein structure, we identified and 
empirically validated three basic amino acid residues in PUR repeats I, II, and III that are 
critical for ACTA2 repression in fibroblasts. Our findings suggest that a combination of 
hydrophobic and electrostatic interactions contribute to the ssDNA-binding and 
transcriptional regulatory properties of Pur!. 
 
MATERIALS AND METHODS 
Computational modeling of Pur! . Hydrophobic side chains were identified in a 
Mus musculus Pur! homology model using PyMOL to depict regions of Pur! with high 
hydrophobic amino acid content (33,34). Additionally, electrostatic surface maps were 
generated to identify solvent-exposed, charged amino acids. To select positively charged 
amino acid residues of Pur! that might confer ACTA2 repression, a ClustalW multiple 
pairwise sequence alignment of Mm Pur! and Dm Pur" was performed to identify Pur! 
residues corresponding to the Pur" residues (R80, R180, and R226) that had been 
mutated to abolish single-strand nucleic acid interaction (35-37). The lack of 
conservation of Pur" R180 led us to align the crystal structure of Dm Pur" (amino acids 
40-185) and the homology model of Mm Pur! I-II to identify a positionally conserved 
arginine in spatial proximity to Pur" R158.  
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Single-Stranded DNA-Binding Assays. Direct ssDNA-binding colorimetric 
ELISAs were performed in the presence of varying levels of deoxycholate or NaCl with 
pure proteins and a synthetic 3’ biotinylated single-strand oligonucleotide derived from 
the ACTA2 promoter-enhancer spanning bp -195 through -164 (PE32-bF) as described 
previously (32,38). These ssDNA-binding ELISAs were carried out by incubating 1 nM 
Pur!, 1 nM Pur! I-II-II, or 5 nM Pur! III with 0.5 nM solid-phase PE32-bF in the 
presence of varying concentrations of deoxycholate or NaCl (Sigma). Solid-phase 
Pur!:PE32-bF complexes were detected with an antibody directed against amino acids 
210-229, a secondary antibody conjugated to horse radish peroxidase (20), and the 
addition of colorimetric substrate, ABTS (Sigma Aldrich). Data points were fit to a four-
parameter variable-slope equation to obtain an IC50 value (Prism 6, Graphpad Software, 
Inc.).  
Construction of Expression Vectors. The mammalian expression plasmid 
encoding full-length N-terminal hexahistidine-tagged mouse Pur! (pCI-NHis-Pur!) was 
generated in a previous study (14,20). The QuikChange+ Primer Design Program 
(Stratagene) was used to design primers for site-directed mutagenesis of the pCI-NHis-
Pur! template. Mammalian pCI-NHis-Pur! expression vectors encoding selected point 
mutations were generated using the QuikChange® XL site-directed mutagenesis kit 
(Agilent). Mutated plasmids were sequence validated (Vermont Cancer Center DNA 
Analysis Facility) and purified by double cesium chloride gradient centrifugation. 
Quantification of purified plasmids was achieved by measuring the optical density at 260 
nm. Double restriction enzyme digestion with BamHI and KpnI was used to evaluate 
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plasmid purity from genomic DNA and to confirm the size of the restriction digestion 
products via analytical agarose gel electrophoresis. The expression plasmids generated 
encoded different combinations of single, double, and triple mutations including Pur! 
K82A, R159A, R267A, K82A/R159A, K82A/R267A, R159A/R267A, and 
K82A/R159A/R267A.  
Transient Transfection Assay. AKR-2B mouse embryo fibroblasts (MEFs) were 
seeded at 4.0 % 104 in McCoy’s 5A medium supplemented with 5% heat-inactivated FBS 
in 6-well plates. Cells were incubated at 37°C in an incubator with 5% CO2 for 24 h to 
facilitate adherence to the plate. MEFs were transiently transfected with a total of 2 µg of 
DNA consisting of 0.1 µg of pSV40-!Gal, 1 µg of expression plasmid encoding single, 
double, or triple point mutations, and 0.9 µg of promoter-reporter construct, pVSMP8-
luciferase (33). After 48 h incubation at 37°C, transfected cells were washed with PBS 
and harvested by lysis in 1% Passive Lysis Buffer (Promega) containing protease 
inhibitors. Luciferase activity assays (Promega) were used to evaluate luciferase reporter 
expression which was normalized for total protein concentration determined by Bradford 
assay. Datasets were analyzed by performing a one-way analysis of variance and 
Dunnett’s multiple comparison test with significance of p <0.05 (Prism 6, Graphpad 
Software, Inc.).  
Immunoblotting. Total soluble protein from cell lysates was precipitated by 
addition of 5  volumes of cold ethanol and incubation at –20°C for 1 h. Insoluble protein 
was collected by centrifugation and dissolved in 1% SDS-PAGE loading buffer (20 mM 
Tris-Cl, pH 6.8, 0.5% w/v SDS, 5% v/v glycerol, 0.005% w/v bromophenol blue, 5% v/v 
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!-mercaptoethanol), heated for 3-5 minutes at 100°C, and run on a 12% w/v 
acrylamide/bisacrylamide (29:1) mini-gel with molecular weight standards (BenchMark 
Prestained Protein Ladder, Invitrogen). Protein (10 µg or 20 µg) was transferred to an 
Immobilon-P polyvinylidene difluoride membrane (Millipore) at 125V for 90 min at 4°C 
in 25 Trizma base, 192 mM glycine, 20% v/v methanol. His-tagged Pur! proteins were 
detected with a mouse anti-RGS-His monoclonal antibody (Qiagen, 1.0 µg/ml) followed 
by a goat anti-mouse IgG-HRP antibody. Bands were visualized via chemiluminescent 
detection (Pierce® ECL Western Blotting Substrate).  
 
RESULTS 
Mapping of hydrophobic and ionic regions in the Mm Pur!  homology model. 
The chemical properties of amino acid residues in the Mm Pur! homology model were 
displayed using hydrophobic and electrostatic maps generated in PyMOL (33). As 
expected, hydrophobic amino acid residues were located at the interior of the 
intramolecular (PUR repeat I-II) and intermolecular subdomains (PUR repeat III) (Figure 
1A, B). Hydrophobic side chains in the !!!!" structure formed by each PUR repeat 
protrude away from solvent-exposure and in toward the interface of two PUR repeats. 
This model suggests that a hydrophobic core is located at the center of each PUR 
subdomain.  
Electrostatic maps of solvent-exposed residues in the Mm Pur! model exhibited a 
negative charge localized around the "-helices of each PUR subdomain and pockets of 
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positively charged residues on the !-sheet surface (Figure 1C, D). Interestingly, the PUR 
I-II intramolecular domain exhibited one positively charged pocket on the surface of the 
!-sheets while evidence of two positively charged channels existed at the surface of the 
!-sheets in the PUR III intermolecular subdomain (Figure 1D). These results are 
consistent with surface charge maps of the Dm Pur" I-II crystal structure which exhibited 
moderately negative charge on the "-helix surface side and positive charges around the 
!-sheets (28,29). The positively charged channels localized around the !-sheets of the 
PUR subdomains point to potential binding surfaces for negatively charged nucleic acid.  
Three basic amino acid residues located in !-strands of each PUR repeat were 
selected for mutagenesis based on the reported ability of analogous residues to mediate 
RNA-binding by Pur" (Figure 3A-F) (37). Alignment of Pur" and Pur! sequences 
revealed that Pur" residues R80 and R226 were positionally conserved in Pur! and 
corresponded to residues K82 and R267 located in the fourth !-sheet of the PUR I and 
PUR III repeats in the Pur! homology model. The absence of a conserved basic residue 
in the PUR II repeat led us to align the PUR repeat I-II subdomain of the Mm Pur! 
homology model with the Dm Pur" I-II structure (28,33). This maneuver revealed a 





Figure 4- 1. Hydrophobic and electrostatic surface maps of Mm Pur! computational 
model. (A) Hydrophobic amino acid residues of the Mm Pur! dimer model. Yellow 
spheres represent hydrophobic amino acids while purple represents non-hydrophobic 
residues. (B) Representation of (A) rotated 180° around the horizontal axis. (C) 
Electrostatic surface maps of the Mm Pur! dimer show regions of charged amino acids. 
Blue areas indicate positively charged residues and red represents negatively charged 




















Effect of deoxycholate on cis-element binding by Pur! . To investigate whether 
hydrophobic interactions play a role in Pur! nucleoprotein complex formation, ssDNA-
binding ELISAs were conducted in binding buffer supplemented with increasing 
concentrations of the anionic bile salt detergent, sodium deoxycholate (Figure 2A). The 
amphiphilic properties of deoxycholate allow the detergent to interact with hydrophobic 
surfaces of proteins in a non-cooperative and non-denaturing manner (39). Consequently, 
deoxycholate is useful in disruption of protein-protein interaction (40,41). A 3’ 
biotinylated single-stranded oligonucleotide corresponding to the purine-rich sense strand 
of the MCAT enhancer motif of ACTA2 (5’-
GGGAGCAGAACAGAGGAATGCAGTGGAAGAGA-3’, PE32-bF) was used as the 
ssDNA probe. This oligonucleotide has previously been shown to form high-affinity 2:1 
Pur!:PE32-F nucleoprotein complex with a macroscopic Kd of approximately 0.3 nM 
(31). The binding step of the assay was executed with a limiting concentration of PE32-
bF (0.5 nM) and a 2-5 fold molar excess of purified recombinant Pur! proteins in the 
presence of varying concentrations of sodium deoxycholate. Results show that very low 
concentrations of deoxycholate (< 0.0156% or 0.38 mM) had little to no effect on Pur! 
binding to ssDNA. However, at deoxycholate concentrations exceeding 1 mM, binding to 
PE32-bF was markedly inhibited for full-length Pur! (IC50 = 0.098%, 2.36 mM), the core 
Pur! I-II-III construct (IC50 = 0.084%, 2.03 mM), and the isolated Pur! III intermolecular 
subdomain (IC50 = 0.060%, 1.45 mM). The deoxycholate-sensitivity of all three 
constructs is consistent with previous findings in which the specific inhibitory effect of 
deoxycholate on Pur" and Pur! interaction with ssDNA was documented by band shift 
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assay in comparison to Triton X-100 (20). These results are in keeping with structural 
data implicating hydrophobic interactions as the principal driver of both intramolecular 
and intermolecular association of PUR repeats in Pur" (29). 
Effect of increasing ionic strength on cis-element binding by Pur! . To 
evaluate the involvement of electrostatic charges in Pur!-ssDNA interaction, the effects 
of increasing NaCl concentration on the interaction of full-length Pur!, the core I-II-III 
construct, and the isolated Pur! III subdomain with PE32-bF was monitored by ELISA 
(Figure 2B). Results indicated that salt concentrations greater than ~0.5 M abolished the 
binding of each Pur! construct to PE32-bF. Given the similarity of the competition 
curves, these data suggest that each Pur! subdomain possesses charged amino acids 
required for stable nucleoprotein complex formation.  
Identification of K/R residues in PUR repeats I, II, and III that are essential 
for Pur!  repressor activity. To evaluate the consequence of K82A, R159A, and R267A 
point mutations on the ACTA2 repressor activity of Pur!, MEFs were co-transfected with 
Pur! expression vectors and an ACTA2 promoter-reporter construct (VSMP8-luciferase) 
(33). All point mutations tested reduced the repressor activity of Pur! toward the VSMP8 
promoter activity in MEFs. Effects of double and triple point mutations were more 
pronounced than single point mutations. Immunoblotting of the cell lysates confirmed 
that all Pur! point mutants were stably expressed in MEFs (Figure 4B). Interestingly, 
Pur! constructs containing the PUR repeat III R267A mutation exhibited greatly 
diminish Pur! repressor activity indicating that R267 plays a critical role in Pur! 
nucleoprotein complex formation. In addition, the Pur! K82A/R159A/R267A triple and 
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Pur! R159A/R267A double mutants were much weaker repressors than the R267A 
mutant alone. These data suggest that basic residues in each Pur! subdomain are involved 
in ACTA2 promoter recognition. This finding is consistent with the cooperative, multisite 
binding mechanism proposed for Pur! (31). The results of transient co-transfection 
assays comparing the ACTA2 repressor activity of varying concentrations of Pur! 
K82A/R159A/R267A and R159A/R267A validated the near complete loss-of-function 
phenotype of these mutants relative to wild-type Pur!.   
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Figure 4- 2. Effect of deoxycholate and salt on Pur!-ssDNA interaction. (A) Purified, 
recombinant NHis-Pur!, NHis-Pur! I-II-III and NHis-Pur! III were incubated with 0.5 
nM biotinylated PE32-bF in binding buffer containing varying concentrations of 
deoxycholate. Solid-phase nucleoprotein complexes were detected by ELISA. (B) The 
same ELISA format was used to evaluate the effect of varying salt concentrations on the 


























Figure 4- 3. Homology model of Mm Pur! highlighting basic residues implicated in 
ssDNA-binding. (A) Space-filling model of the Mm Pur! dimer depicting surface 
exposure of K82 (red), R159 (blue), and R267 (purple). (B) Figure (A) rotated 90° 
around the horizontal axis clearly shows the location of K82 and R159. (C) A 3D ribbon 
model of the Mm Pur! dimer highlighting the location of the selected basic residues. (D) 
Figure (C) rotated 90° around the horizontal axis. (E) Electrostatic surface maps of the 
Mm Pur! dimer showing distinct regions of charged amino acids. All selected basic 
amino acids are located within positively charged clusters (blue areas). (F) Figure (E) was 




Figure 4- 4. Mutation of selected basic amino acid residues inhibits the ACTA2 repressor 
activity of Pur! in fibroblasts. (A) Subconfluent AKR-2B MEFs were transiently co-
transfected with mammalian expression plasmids encoding either wild-type Pur! or the 
indicated point mutants and an ACTA2 promoter-luciferase reporter plasmid, VSMP8. 
After 48 h, transfected MEFs were harvested and whole cell extracts were assayed for 
luciferase enzyme activity and total protein concentration. Luciferase reporter expression 
measured in cells co-transfected with an empty pCI vector control was defined as 1. Bars 
show the fold repression of the VSMP8 reporter by each Pur! construct (mean ± SEM, n 
= 6-15). (B) Immunoblot analysis was performed to confirm the expression of single, 
double, and triple NHis-Pur! point mutants in cell lysates prepared in (A). (C) A titration 
assay was performed with plasmids encoding the indicated double and triple Pur! point 
mutants in comparison to the wild-type protein. Symbols show the relative VSMP8 
repressor activity of each Pur! construct (mean ± SEM, n = 3). (D) Immunoblot analysis 
was performed to confirm the dose-dependent expression of NHis-Pur! in cell lystates 




 During tissue repair, trans-differentiation of fibroblasts lead to the formation of 
contractile myofibroblasts expressing SM"A. Persistent myofibroblast activation results 
in pathological tissue remodeling associated with many fibrotic diseases. A better 
understanding of the underlying molecular pathways that regulate ACTA2 transcription in 
myofibroblasts is necessary to develop better strategies for treating aberrant fibrosis. Pur! 
is a transcriptional repressor that interacts with the MCAT enhancer of ACTA2 to prevent 
the binding of trans-activators which induce SM"A gene expression.  
To identify the specific structural elements in Pur! that mediate protein binding to 
purine-rich ssDNA, we evaluated the contribution of hydrophobic and ionic amino acids 
to Pur! nucleoprotein interaction with an ACTA2 promoter-derived ssDNA probe (Figure 
2). Our results indicated that the anionic detergent, deoxycholate, inhibited ssDNA-
binding of Pur! proteins composed of all three PUR repeats and the PUR III 
intermolecular subdomain at concentrations greater than 0.06%. Additionally, at salt 
concentrations exceeding 0.6 M, protein binding to ssDNA was abolished in the case of 
full-length Pur!, Pur! I-II-III, and the Pur! III intermolecular domain. These results 
suggest that a combination of hydrophobic and electrostatic interactions contribute to the 
assembly of Pur!-PE32-bF complex. We surmise that the hydrophobic core of each 
subdomain ensures the structural stability of each ssDNA-binding module while basic 
residues on the surface serve to mediate subdomain contact with nucleic acid (Figure 1). 
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This explanation is consistent with the subdomain architecture of the Pur! dimer and 
cooperative mechanism of nucleoprotein complex assembly (31,33).  
To evaluate the effect of PUR repeat-specific K82A, R159A, and R267A point 
mutations on Pur! function (Figure 3), single, double, or triple mutants were expressed in 
undifferentiated MEFs and assayed for their ability to repress an ACTA2 promoter-
luciferase reporter gene. (Figure 4). The results showed that Pur! constructs containing 
the R267A mutation were the most defective in ACTA2 repressor activity. Of the mutants 
tested, Pur! R159A/R267A, K82/R159/R267, and K82A/R267A demonstrated the 
greatest loss of ACTA2 repressor activity (Figure 4 A, B). These findings suggest that 
residue R267 in PUR repeat III plays a critical role in mediating Pur! repressor activity 
but that residues K82A and/or R159A in PUR repeats I and II contribute to ACTA2 
repression as well. This interpretation was further validated by confirming that the 
deficiency in repressor activity in the Pur! R159/R267 and Pur! K82A/R159A/R267A 
mutants was seen over a range of expressed protein concentrations (Figure 4 C, D). It is 
important to note that analogous mutations in the 4th !-strand of PUR repeats I, II, and III 
of Dm Pur" have been reported to abolish RNA-binding in the absence of any effect on 
Pur" dimerization (37). Consequently, the loss of ACTA2 repressor function observed 
with the Pur! K82, R159, R267 mutants is most likely due to a deficiency in purine-rich 
ssDNA-binding affinity although we cannot formally exclude the possibility of altered 
subcellular trafficking of the expressed Pur! point mutants. Further biochemical studies 
are required to empirically validate the predicted structural features and ssDNA-binding 
properties of these Pur! point mutants relative to the wild-type protein. These studies will 
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include the use of circular dichroism spectroscopy to assess protein folding and stability, 
size exclusion chromatography to evaluate quaternary structure, and ssDNA-binding 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS !
The studies presented herein have established a structural basis for site-specific 
ssDNA-binding of Pur! to the sense strand of the ACTA2-derived cryptic MCAT 
enhancer element (PE32-F). Our findings show that the functional Pur! dimer consists of 
three subdomains that interact cooperatively with PE32-F to form a repressive 
nucleoprotein complex. The molecular arrangement of subdomains consists of an 
intermolecular PUR domain made up of PUR III repeats from two Pur! molecules 
flanked on either side by intramolecular subdomains consisting of PUR repeats I-II. The 
inter- and intramolecular subdomains are structurally similar but functionally unequal in 
ssDNA-binding capacity. In our most recent study, we show that specific basic amino 
acids within the !-sheets are essential for full ACTA2 repression by mouse Pur!. 
Specifically, mutation of R267 individually and in combination with K82 and R159 
resulted in a significant reduction in ACTA2 repression.  
Biochemical analysis of Pur! K82A, R159A, and R267A individually or as 
double and triple point mutants is essential for elucidating the underlying molecular 
mechanism of ACTA2 repression by Pur!. First, the ssDNA-binding properties of AKR-
2B MEF lysate-derived Pur! point mutants will be evaluated using a ssDNA-binding 
ELISA. Cell lysate-derived Pur! constructs that impact ssDNA-binding will be evaluated 
using biochemical techniques. Bacterial expression plasmids will be generated by 
subcloning the open reading frame from the pCI mammalian expression vectors into the 
bacterial competent expression plasmid, pQE30. Stable expression of Pur! constructs in 
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E. coli will be assessed by immunoblotting. To evaluate the biochemical characteristics 
of point mutations that impair the ACTA2 repressor activity of Pur!, we will purify 
recombinant NHis-tagged Pur! proteins harboring the point mutations using affinity 
column chromatography. The quaternary structure of each isolated Pur! construct will be 
evaluated using calibrated SEC and the fold state of each protein will be assessed by CD. 
Finally, the ssDNA-binding capacity of each Pur! point mutant will be examined using 
colorimetric ssDNA-binding assays. 
Future studies will focus on characterization of individual amino acids and 
sequence elements that confer site-specific binding at the MCAT enhancer of the ACTA2 
promoter. Crystallization trials with the Pur! I-II intramolecular subdomain and the Pur! 
III intermolecular subdomain will be carried out in attempt to solve the x-ray crystal 
structure of Pur!. Furthermore, amino acid sequences unique to Pur! may account for the 
differences in Pur protein structure that distinguish Pur! as the dominant ACTA2 
repressor in muscle cells. Site-directed mutagenesis of these unique amino acids may 
provide insight into the intrinsic biochemical differences between Pur! and Pur" that 
contribute to site-specific binding to purine-rich ssDNA. 
Future studies will also be directed at evaluating the effect of nucleoprotein 
complex formation on duplex DNA destabilization. Mammalian genetic regulation 
requires transcriptional repressors and activators to access sequence elements within the 
supercoiled dsDNA. The mechanism by which ssDNA-binding transcription factors, such 
as Pur! and Pur", acquire access to the constrained double-stranded helix remains 
unknown. Several studies have indicated that Pur" may be capable of unwinding duplex 
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DNA in the absence of ATP (1, 2). Pur" and Pur! do not exhibit helicase activity 
suggesting that they may possess the capacity to destabilize the dsDNA helix (2). 
Another ssDNA-binding protein, phage T4 gene 32 protein (gp32), mediates ATP-
independent strand unwinding similar to Pur" (3). This indicates that ATP-independent 
duplex unwinding may be a mechanism carried out by various ssDNA-binding proteins. 
As we have shown in the presented studies, the unique tripartite arrangement of Pur! is 
optimal for interaction with the MCAT enhancer element. To evaluate whether this 
arrangement also facilitates duplex DNA unwinding, we will use base modifying 
chemical reactions and electrophoretic mobility shift assays to evaluate helix unwinding. 
Pur! nucleoprotein complexes will be formed on radioactively labeled PE32-F 
oligonucleotides in both single and double-stranded configuration. Reactive base 
modifying chemical probes including dimethyl sulfate (DMS), potassium permanganate 
(KMnO4), and diethyl pyrocarbonate (DEPC) will be used to modify unprotected bases. 
These chemical probes will react with bases exposed in areas of localized or global 
perturbation in the dsDNA. Subsequent exposure to piperidine will mediate cleavage of 
the sugar-phosphate backbone and cleavage products will be evaluated using sequencing 
gel electrophoresis and phosphorimage analysis. Additionally, a DNAse I footprinting 
analysis may be used to evaluate DNA duplex destabilization and identify bases protected 
by Pur! nucleoprotein interaction. 
The studies presented in this dissertation indicate that Pur! acts as a 
transcriptional repressor of ACTA2 expression by cooperatively interacting with the 
MCAT enhancer motif. To evaluate the thermodynamic parameters of Pur!:PE32-F 
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nucleoprotein complex formation, we propose to perform isothermal titration calorimetry 
(9) and a van’t Hoff analysis. ITC experiments will be carried out by titrating full-length 
Pur! into PE32-F. The binding isotherms will be fit to a single-site or multisite model 
and the binding affinity, stoichiometry, and enthalpy change generated from these 
experiments will establish the thermodynamic contributions involved in the cooperative 
nucleoprotein interaction of Pur! with PE32-F. Different states of protein folding and 
protein-ligand interaction are reflected in the difference in Gibbs free energy (!G) (4). 
The standard free energy (!Gº) depends on the equilibrium between two states expressed 
in an equilibrium constant:  
!Gº (T) = -RT ln K(T) 
where K is the equilibrium constant, R is the gas constant and T is the temperature in 
Kelvin. The !Gº of association is based on enthalpy (!Hº) and entropy (!Sº) of the 
system.  
!Gº (T) =!Hº (T) -T!Sº (T) 
 The formation of protein-ligand complexes results in the formation of new bonds and 
interactions such as van der Waals interactions, hydrogen bonding, electrostatic 
interactions, and hydrophobic forces. These interactions directly affect the enthalpy of a 
system. Changes in entropy are also observed as protein-ligand complexes form and 
affect the disorder within a system. Therefore, changes in the thermodynamic parameters 
will indicate the assembly of the Pur! nucleoprotein complex on PE32-F. The 
cooperative assembly of Pur! on PE32-F will likely result in a decrease in entropy 
indicative of nucleoprotein complex formation. In addition, the ITC experiments may be 
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carried out with Pur! intra- and intermolecular subdomains to identify the structural 
elements that facilitate cooperative ssDNA-binding. As an additional method for 
evaluating the thermodynamic parameters of Pur! nucleoprotein interaction, we will 
obtain melting curves using temperature-controlled UV-visual spectroscopic techniques. 
We will determine the melting temperature or midpoint of these binding curves and plot 
1/midpoint versus the natural log of the total concentration. The value of !Hº can be 
determined as a function of temperature using this van’t Hoff analysis. Thermodynamic 
parameters determined using ITC and the van’t Hoff analysis will aid in our 
understanding of the cooperative assembly of the Pur!:PE32-F nucleoprotein complex.  
Posttranslational modifications (PTMs) may also contribute to Pur! function. 
Modification of ssDNA-binding transcription factors with PTMs have previously been 
linked to transcription factor function. PTMs have been shown to govern transcription 
factor subcellular localization, DNA-binding, structural stability, or protein-protein 
interaction with other transcription factors (5). Phosphorylation of serine, threonine, or 
tyrosine by the addition of a phosphate group generates a negative charge around the 
modified amino acid, which may govern cellular signaling, stability, subcellular 
localization, or protein-protein interaction. Methylation of arginine residues has been 
shown to modulate protein-protein interaction and the regulatory switch-like activity of 
transcription factors. For example, methylation of RUNX1 prevents its interaction with 
co-repressor SIN3A resulting in de-repression of RUNX1 genes (6). Acetylation of 
arginine and lysine residues has been implicated in the abolishment of transcription factor 
nucleoprotein complex formation by neutralizing the positive charge with an uncharged 
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amide group. As another example, the interaction between FOXO1 and the glucose-6-
phosphate promoter is abolished by acetylation (7). Lastly, ubiquitination of transcription 
factors targets them for proteasomal degradation. This PTM may control the local 
expression level of transcription factors by inducing their proteolytic digestion. To 
evaluate posttranslational modification of Pur proteins, Pur! or Pur" constructs will be 
expressed in a human embryonic kidney 293 (HEK 293) cells and evaluated by mass 
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